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ABSTRACT
The correlation between alteration in brain sensitivity to barbiturates and changes in brain gamma-aminobutyric acid levels was investigated.

The following con-

ditions were utilized to alter the brain sensitivity of
mice or rats to barbiturates, 1) exposure to hypobaric
hypoxia, 2) septal lesions, 3) tr~atment with desipramine,
sodium nitrite or pargyline, 4) social deprivation, and 5)
abrupt withdrawal following chronic barbiturate or ethanol
administration.

The first three of the s e conditions h a ve

been known to increase the brain sens i tivi t y to barbi t urates, while the last two conditions are known to decrease
the sensitivity of brain neurons to barbiturates.

The brain

levels of gamma-aminobutyric acid were determined after the
above treatments.

Wherever necessary, the mechanism of

alteration in gamma-aminobutyric acid was investigated by
. measuring activities of the enzymes, glutamic acid decarboxylase and gamrna-aminobutyric acid transaminase.

Acute Hypoxia
Exposure of mice to hypobaric hypoxi a (364 mm Hg ,
p02

=

76 rrun Hg ) for JO or 60 minutes a t 22 o r J0°C a mb i ent

tempera t ure, produced elevation in brain le v el s of gamma aminobutyric acid. Only hypoxia was found to aff ect brai n
i

gamma-aminobutyric acid.

Ambient temperature or duration

of hypoxia exposure did not affect or interact with the
effect of hypoxia on brain gamma-aminobutyric acid. These
data suggest that hypoxia induced-elevation in brain gammaaminobutyric acid may lower the threshold of brain neurons
to drug induced depression.

Septal Lesions
Bilateral lesions of the septal area markedly potentiated narcosis due to barbital suggesting that alteration in neuronal excitability had taken place.

There was

no difference in the levels of brain gamma-aminobutyric
acid between the septal rats and sham-operated or normal
control rats.

Therefore, the effect of septal lesions on

the brain sensitivity does not appear to be related to alteration in brain gamma-aminobutyric acid.

Drug Treatments
Desipramine, ambient temperature and their interaction had a significant effect on brain gamma-aminobutyric
acid.

At 22°C, desipramine produced hypothermia and ele-

vated brain gamma-aminobutyric acid levels.

At J0°C am-

bient temperature desipramine ceased to reduce body ternperature and brain gamma-aminobutyric acid.

In mice

treated with desipramine at the lower ambient temperature ,
there was a dose-response relationship between the amount
of drug administered and the elevation in brain gamma-amino-

ii

butyric acid.

Hypothermia due to desipramine appears to be

important in the elevation o:f brain ganuna-aminobutyric acid.
These :findings suggest that reduced brain excitability due
to high garnma-aminobutyric acid may alter the response of
brain neurons to barbiturates.
At 22°C, sodium nitrite produced hypothermia and
raised brain levels of gamma-aminobutyric acid.

At J0°C am-

bient temperature sodium nitrite ceased to af:fect body temperature and brain gamma-·arninobutyric acid. Even though,
hypothermia due to sodium nitrite seems to be important in
elevation of gamma-arninobutyric acid, elevation of gammaarainobutyric acid is the result o:f sodium nitrite's ability
to produce hypoxia.
Pargyline induced potentiation of narcosis due to
barbital was greater at 22°C than at J0°C ambient temperature.

This suggested that pargyline alters the neuronal

sensitivity to barbiturates at both the ambient temperatures.

Pargyline also produced hypothermia and elevated

brain ga.mma-aminobutyric acid at both the ambient temp e ratures.

There was a greater degree of reduction in bod y

temperature and elevation in brain gamma-aminobutyric acid
when mice were treated with pargyline at 22°C.

::!:n pargyline

treated mice, at 22°C, there was a dose-re sponse relationship betwe en che amount of drug adminis t ered and the

d~ 

gree of elevat .i .on in brain garnrna-c>.minobutyric acid.

'l'hesH

observations indicate that

pa::.~gylilli~

indu~ed

hypothernia

causes elevation in brain gan.u"'Ila-aminobutyric acid.

Further~

the increased concentrations of brain ganuna-aminobutyric
acid may in turn lower the threshold of brain neurons to
barbiturates.

Social Deprivation
Chronic deprivation of social stimuli lowered brain
gamma-aminobutyric acid levels, decreased the activity of
the gamma-aminobutyric acid synthesizing enzyme, glutamic
acid decarboxylase and reduced total protein content in the
brain.

The activity of the gamrna-aminobutyric acid degrad-

ing enzyme, gamma-aminobutyric acid transaminase, remained
unaltered.

These data suggest that reduced concentrations

of gamma-aminohatyric a.cid might have raised ar::n1sa.l levels
of the deprived mice such that their
susceptibility to drugs was altE:Yed.

ce~tral

nervous system

1'urther, !'{-) duced

levels of gamma-aminobutyric acid were true reflection::: of
glutamic acid decarboxylase.

Drug Withdrawal
The fluid intake of mice was restricted to increasingly concentrated solutions of phenobarbital for four
weeks.

Abrupt withdrawal resulted in convulsive activity

in response to an auditory stimulation.

There was no alter-

ation in brain levels of garmna-aminobutyric acid in any
the groups tested.

These data suggest that brain gamrna -

aminobutyric acid was not involved in the alteration of
neuronal sensitivity following barbiturate withdrawal .

iv

o!~

Intoxicating blood levels of ethanol were maintained,
by stabilizing blood ethanol-levels with daily injections of
pyrazole, for 96 hours in mice housed in an atmosphere of
ethanol vapour.
withdrawal signs .

On removal from the ethanol, mice developed
The signs were graded to indicate the

time course and intensity of the withdrawal syndrome.

Eight

and twenty-four hours following ethanol withdrawal mice were
tested with barbital.

Both the groups showed marked reduc-

tion in narcosis due to barbital.

These observations sug-

gested that ethanol withdrawal heightened the threshold of
brain neurons to drug induced depression.

The brain levels

o1' gamma-aminobutyric acid were found to be lowered following eight hours of ethanol withdrawal.

This indicates that

lower than normal brain gamma-aminobutyric acid may cause an
increase in neuronal excitability, which is revealed upon
administration of the barbiturate.

v
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INTRODUCTION
Various factors in the environment have been known to
affect physiological processes within the organism resulting
in altered pharmacological response.

Factors such as ambi-

ent temperature (Chance, 1957), atmospheric pressure
(Bernardini, 1 9 69), population density (Chance and Mackintosh, 1962) and seasonal variations (Heller et al., 1957)
may influence the onset, potency or duration of action of a
drug thus altering the resultant pharmacodynamic activity.
Treatments l i ke hypoxia (Robinson et al., 1968), administration of sodium nitrite (Baumel et al., 1971) or desipramine
(Shah and Lal, 1971), or prolonged social deprivation
(Baurnel

tl al., 1970a) have been reported to alter the CNS

sensitivity to barbiturates.

The other conditions which

have been known to alter the neuronal sensitivity to barbiturates include, tolerance or physical dependence on barbiturates (Stevenson and Turnbull, 1970; Wahstrom, 1971)
a n d decerebration or lesions of the septal area (Seguin and
St avraky, 1957; Harvey

tl al., 1964).

The alteration in neuronal sensit i vity can be defined as an al t ered pharmacological response of the neuronal
tissue to s i milar drug concentra tion s .

Al t eration of

pharmacological response due to changes in the metabolism
of the drug or the rate of entry of the drug into brai n is
not included in thi s definition.

~

I

The alteration in neuronal sensitivity to drugs could
sometimes be therapeutically beneficial.

However, undesir-

able response to a drug treatment because of alteration in
neuronal sensitivity to drugs is not very unconunon either.
A better understanding of the mechanisms underlying these
changes may aid in the development of preventive methods to
counteract undesirable effects induced either by a drug
I .
I

I

treatment or an environmental extreme.
It is now well accepted that GABA plays a role as a
specific inhibitory transmitter in the manunalian CNS
(Davidoff, 1972; Ehinger and Falck, 1971).

GABA has also ·

been shown to have non-specific depressant action, when applied directly to the brain of mamnals (Bindman et al.,
1962).

Further, of all the depressant amino-acids, GABA

occurs in largest amounts and it is uniquely present in
the nervous tissue (Roberts, 1956).

By virtue of these

characteristics, alteration of GABA levels in the neuronal
environment may be expected to alter the threshold of brain
neurons to drug induced narcosis.
that support this suggestion.

There are several points

They are sununarized as be-

low:
1.

Treatments like desipramine (Shah and Lal, 1971), so-

dium nitrite or hypoxia ( Ba umei et al., 1971, 1970b) caus e
hypothermia and potentiate barbitura te induced n a rcosis at
22°C but have no such effect at J0°C ambient tempera t ure.
Shah and Lal (1971) noted t h e finding of Oja ~al.
that hypothermia elevates the brain levels of GABA.

(1968)

8

2.

Sodium nitrite induced potentiation of barbiturate nar-

cosis was reversed by hyperba ri c oxyge n (OHP ) (Baumel et al.,
1971), a treatment known to cause marked reduction in brain
GABA (wood et al., 1967).

J.

Hypoxia increased brain GABA ( Woo d et al., 1968), which

enhanced the depression of brain neurons so that barbiturate
induced-narcosis was potentia.te d (Baumel et al., 1970b).
Moreover, hypoxia antagonized convulsions induced by semicarbazide or methionine sulphoxamine (Eaumel et al., 1969a,
1969b), drugs known to decreas e:: brain levels of GABA (Killam
and Bain, 1967; Roberts and Frankel, 1951; Lamar and Sellinger, 1965).
This investigation was undertaken to investigate the
correlation between alteration in brain sensitivity to barbiturates and changes in brain GABA-leYels.
Based upon the hypothesis, the predictions which were
undertaken for testing are:
1.

That brain GABA-levels will be elevated by a variety of

conditions known to increase the CNS sensitivity to barb i turates, these conditions will include:
a)

exposure to hypobaric hypoxia

b)

septal lesions

c)

treatment with desipramine, sodium nit rite or

pargyline
2.

That brain levels o f' GABA will be decreased by condi-

tions kno;vn to 101rnr the CNS sensitivity to barbiturates,
these condi tions wil l include:

9

a)

social deprivation

b)

abrupt withdrawal following chronic barbiturate

or alcohol administration
It was therefore undertaken to subject the animals
to all of the aforementioned conditions or treatments and
then measure their brain GABA-levels, in order to establish that alteration of GABA-levels in the neuronal environment will alter the threshold of brain neurons to drug
induced depression.

10

LITERATURE SURVEY
GABA
Gamma-aminobutyric acid first appeared in the literature in 1883 when the synthesis of a compound named
"piperidinsaure" was reported (Baxter, 1970).

But its

presence in neurological tissue was not recognized until
1950 (Roberts and Frankel, 1950; Awapara et al., 1950;
Udenfriend, 1950).

High levels of GABA a~e found in the

peripheral nerves of crustaceans and in the central nervous
system- brain, spinal cord and retina- of vertebrates.
In the central nervous system of mammals the "GABA
shunt" (Figure 1) represents an alternate pathway in the
portion of the tricarboxylic acid cycle that leads from
alpha-keto glutarate to succinate.

The carbon chain of

alpha-keto glutarate can be converted via glutamic acid
and GABA to succinate and

co 2

(Baxter, 1970).

The "GABA

shunt" involves three enzymes, namely, glutamic acid decarboxylase (GAD), gamma-amino butyric acid- alpha-keto
glutaric acid transaminase (GABA-T) and succinic semialdehyde dehydrogenase (SSA-D) (Roberts and Kuriyama, 1968).
The close correlation between the level of GAD and GABA,
in almost a ll areas of brain tested, suggest that GAD is
the only significant enzymatic p a thway leading to GABA in
nerve tissue (Baxter, 1970).

The major pathway of GABA

-----

//

i/

Oxalocetate

.............

"'

\

oC.-Ketoglutarate

C.itrate

2
GAD

Tricarboxylic
Acid
Cycle

'-

GLUTAMATE

1

GAMM.A AMINOBUTYRATE
(GABA )
Succinate

'

......._

__,,,.,

/

/

GAD = L-GLUTAMATE DECARBOXYLASE
GABA - T =GABA , GLUTAMATE TRANSAMINASE
Gdh = L-GLUTAMATE DEHYDROGENASE
SSAdh = SUCCINIC SEMIALDEHYDE DEHYDROGENASE

3 GABA-T

\

~

SUCCINIC
SEMIALDEHYDE

Figure 1.
GAMMA-AMINOBUTYRIC ACID SHUNT.
Pathways 2-4 represent the "GABA shunt"
around pathway 1 of the tricarboxylic acid cycle.

''""""""

12
degradation is via transamination with alpha-keto glutarate
to form glutamate and succinic semialdehyde, GABA-T has been
shown to be involved in this reaction (Baxter and Roberts,

19 58).
The enzyme L-glutarnic acid decarboxylase (GAD) is
found only in the central nervous system, largely in gray
matter and most highly concentrated in nerve endings (Balazs
et al., 1966; Salganicoff and DeRobertis, 1965).

On the

other hand, GABA-alpha-keto glutarate transaffiinase (GABA-T)
is found in high concentrations in the C)>'"toplasmic constituent of the gray matter (Roberts and Kuriyama, 1968).
Both GAD and GABA-T are vitamin B

6 dependent enzymes (Bax-

te:!', l9'70).
GABA as a S;.·-:!cific I nhibi to-ry

1:?.~ansm:!.tt~r

and a Non-Specif-

ic Deoressant Substance
GABA was established as a.n irL1libi tory "transmitter
at the crustacean neuromuscular junction several years ago
(Kravitz~ al.,

1965; Otsuka et al., l966).

Since then,

evidence for GABA as a neurotransmitter in mammalian central nervous system has rapidly grown.

At present, GABA

appears to be an important inhibitory transmitter in
mammalian CNS.
GABA in Crustacean Neuromuscular Junction:
Inhibitory neurons

o~

the lobster contain a large

amount of GABA; its concentra tio n in inhibi t ory axons is
about 100 times hi gher t11an that in excitat ory axons

13
{Kravitz et al., 1965).

There is a remarkable parallel be-

tween the action of GABA on crayfish neuromuscular junction
and that of neural i1iliibitory transmitter.

For instance,

both actions are antagonized by picrotoxin (Takeuchi and
Takeuchi, 1965).

Finally, it has been shown that GABA is ·

released from inhibitory nerves of the lobster in response
to stimulation (Otsuka et al., 1966).

--

GABA in Mammalian Brain
The depressant effects of GABA on the mammalian CNS
have also been intensively studied and efficiently demonstrated in various laboratories.

For example, the rapid

and reversible depressant effects of GABA on electrical activity in the cerebral cort ex were demonstrated by Iwama
and Jasper (1957) and by Purpura et al.

(19.57).

A depres-

sant action of GABA on cortical r.eurons was also demonstrated in the rat (Mahnke and Ward, 1960) and in surgically isolated (main circulation intact) cerebral cortex in
the dog (Rech and Domino, 1960).

Several other reports

indicate that GABA, when applied directly to the brain

o!~

mammals, has a no~-specific depressant action (Curtis and
Watkins, 1960; Bhargava and Srivastava, 1964).
Particularly good evidence for GABA as an in.hibttory
neurotransmitter has been obtained in several areas of the
mammalian brain, e.g., in cortical neurons (Krnjevic and
Schwartz, 1967), Deiter's neurons (Obata et al., 1967;
Otsuka, 1972) and cuneate nucleus of the brain stem (Galindo

14
et al., 1967).

Recent reports by Davidoff (1972) and

Ehinger and Falck (1971) further support the possibility that
GABA is an inhibitory transmitter in the spinal-cord and the
brain.
Besides GABA, other inhibitory amino acids are also
present in the brain, namely taurine, B-alanine, glycj_ne and
alanine (Tallan et al., 1954), hypotaurine (Bergeret and
Chatagne, 1954) and guanidini-acetic acid (Pisano and Udenfriend, 1958).

Nevertheless, of all the depressant amino

acids, GABA occurs in largest amounts; moreover, it occurs
uniquely in nervous tissue (Roberts, 1956).

GABA and Convulsions
Wolfe and Elliott (1962) have reviewed the evidence
for the role of GABA in convulsions unde= a variety of condi tions.

Since then, many correlative studies have been

done, which can be summarized as follows:
1.

intravenous or intraperitoneal GABA protected against
drug-induced convulsions in monkeys (Kopeloff and
Chusid, 1965).

2.

in.tracisternal GABA suppressed seizures induced by intracisternal L-glutamate and pyridoxal-5-phosphate
(Wiechert and Herbst, 1966).

J.

intravenous GABA produced sleep in chicks before the
development of the blood-brain barrier and protected
against pentylenetetrazole induced convulsions in 1day-old chicks (Kobrin and Seifter, 1966).
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4.

Topical GABA inhibited the spontaneous epileptiform
activity and diminished the amplitude of the surface
negative wave of responses evoked by means of stimulation to the olfactory bulb (Guerrero-Figueroa et al.,

1964).
5.

The systemic administration of L-glutamic acid and
amino oxyacetic acid (AOA), both known to elevate
brain levels of GABA, protected animals against audiogenic seizures (Schlesinger et al., 1968).

6.

GABA hae also been observed to protect against audigenic seizures in. mice, whether applied directly to
the cortex (Ballantine, 1963), or administered systemically (Pasquini, et al., 1968) .

7.

exposure of animals to hypobaric oxygen (OHP) decreased
brain GABA and produced convulsions (Wood et al., 1963).
GABA administration protected these animals against
convulsions (Wood et al., 1963).

ACUTE HYPOXIA
The te:;-m "hypoxia" means decreased availability of
oxygen to

~he

cells of the body.

This condition may be

caused by pulmonary disease (Oswald and Fry, 1962), circulatory insufficiency (Finley et al., 1962), anemias and
tissue edema (Van Liere and Stickney, 1963).

A common form

of hypoxia encountered by aviators, as ·trcnauts and others
working at high altitudes or in controlled gaseous environments is inadequate oxyg enatio!l of lungs due to a def·iciency
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of oxygen in the atmosphere.

Hypoxia Due to Reduced Barometric Pressure
The total pressure of' all gases in the air (barometric pressure) decreases as one ascends to higher altitudes.
At sea level or normal room atmosphere, barometric pressure
averages 760 mm Hg and the pressure contributed by oxygen
to the total pressure (partial pressure, po 2 ) is 159 mm Hg.
Since oxygen remains at slightly less than 21% of' the total
gaseous atmosphere, the p02 will decrease with corresponding decreases in total barometric pressure.

Thus at

10,000 ft. barometric pressure=523 mm Hg and p0 2 =110 mm Hg,
whereas at 19,000 ft.

the barometric pressure is 365 mm Hg

and p0 2 =76 mm Hg, equivalent to a 10% oxygen atmosphere at
sea level (760 mm Hg).
Up to an elevation of approximately 10,000 ft. the
p0

2

in the air is sufficient to maintain arterial oxygen

saturation at about 90%.

However, above 10,000 ft. ele-

vation, arterial oxygen saturation falls progressively to
approximately 70% at 19,000 f't. and still lower at higher
altitudes, severely reducing the supply of oxygen delivered by blood to the tissues (Folk, 1966).

HyPoxia and Brain Sensitivity
Baumel et al.

(1969a; 1969b; 1969c; 1970b) have pre-

·sented evidence that exposure of mice to hypoxia (364 mm Hg,
p0 =76 mm Hg) increased the sensitivity of brain neurons to
2
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drug induced

dep~ession.

The evidence can be summarized as

follows; the hypo x ic exposure:
1.

at 22°C and J0°C ambient temperature, significantly increased the duration of

~arcosis

due to barbital,

pentobarbi tal, chloral hydrate and shortened the onset
of narcosis due to barbital in mice.
2.

at 22°C ambient temperature, significantly lowered
pentobarbital whole-body levels at awakening in mice.

J.

antagonized convulsions induced by, a) semicarbazide,
methionine sulphoximine or m-fluorotyrosine, and b)
intracerebral semicarbazide.
The hypo x ic exposure at 22°C and J0°C ambient temper-

ature, decreased absorption of barbital-c

14 from the site

of injection but did not alter penetration of barbital-c

14

into brain.
Baumel et al.

(1970) also reported that the exposure

of the animals to hypoxia at 22°C ambient temperature resulted in significant reduction in body temperature and
that this effect was abolished at J0°C ambient temperature.

Hypoxia and GAnA
Exposure to hypoxia

(5-8% o2 )

f'or more than 10 min-

utes has been shown to elevate brain GABA significantly in
the mouse, hamster, rat, guinea pig and rabbit, with maximum elevation occurring at 60 minutes and the GABA falling
off gradually the re after (Wood, 196 '"( ; Wood et al., 1968).
Wood has

al~o

suggested that GAEA possibly plays a homeo-
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static role in brain metabolism in hypoxic condition (Wood,

1967).

SEPTAL LESIONS
Septal Lesions and Brain Sensitivity
Subcortical lesions may affect an animal's sensitivity
to barbiturates. Heller et al.

(1960) found that lesions in

the septal area of the basal telencephelon in rats caused a
J-to-4 fold increase in both thiopental and barbital induced
narcosis as compared with normal controls.

The septal le-

sions also reduced the time for induction of narcosis by
barbital by one-half (Harvey et al., 1964).

This increase

in barbiturate sensitivity has been sho-v.rn to be specific to
septal regions since lesions of comparable size in cortex
and in caudate nucleus do not significantly alter barbiturate induced narcosis (Harvey et al., 196J).

The increased

sensitivity of the central nervous system to barbiturates
could not be attributed to the effects of lesions on body
weight, temperature regulation, drug ILletabolism, adrenal
function or total brain levels of the drug (Roth and
Harvey, 1968).

Brain Lesions and Chemical ChangP-s
Many of" the lesion studies done in connection with
barbiturate ac <;i on have been reported to produce subst antial decreases in b:ra.in· · concentration of s erotonin, norepinephrine and d.opamiir..e

(He.:~_e r ~ al, ,

196.2); H8.rvey et al.,
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1963; Harvey, 1965; Simpson et al., 1967).
Harvey (1965) suggested that increase in sensitivity
to a drug after subcortical lesions (Septal or dorsomedial
tegmentum) may be due to the effects of the lesions on
chemical processes in the remaining portions of the brain
which are both similar to and additive with the effects of
the drug.

DRUG TREATMENTS
Sodium Nitrite
A great many substances such as nitrites, phenacetin,
acetanilide, sulfanilamide, nitrobenzene and

analin~

can

produce mathemoglobinemia (Bodansky, 1951). Methemoglobin
cannot carry oxygen, so the delivery of oxygen to the tissues is impaired (Darling and Roughton, 1942).

Sodium Nitrite and Brain Sensitivity
Baumel et al.,

(1971) have reported evidence that

pretreatment of animals with sodium nitrite enhances the
depression of brain neurons.

The evidence can be summar-

ized as follows; sodium nitrite pretreatment:
l.

at 22°C ambient temperature, markedly increased the
duration of' narcosis due to barbital or hexobarbital,
shortened the onset of narcosis due to barbital and
produced hypothermia in mice.

However, at J0°C

ambient temperat u re tht! hypothermic efi' ect was abolished as was the i ncrease in duration narcosis due to
barbital.
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2.

significantly lowered the hexobarbital whole-body levels
in mice at awakening.

J.

protected mice against intracerebral semicarbazide induced convulsions.

4.

induced potentiation of barbiturate narcosis was prevented by hypcrbaric oxygen ( OHP), a trea-r;ment kn.own
to reduce brain levels of GABA (Wood, .£.E_ al., 1963).
Sodium nitrite reduced absorption of' barblta1-c 14 from

the site of injection but did not alter its penetration into brain.

Desioramine
Like many drugs, desipramine (DMI) and its parent
substance imipramine, interact with other compounds in a
complex manner.

These two tricyclic anti-depressants en-

hance the action of amphetamine (Carlton, 1961) and tremorine (Sjoquist and Gillette, 1965); they potentiate hypothermia due to infusion of NE, epinephrine or isoprenaline
(Jori and Garrattini, 1965) and imipramine prevents or
cow~teracts hypothermia induced by ~eserpine (Garrattini

and Jori, 1967).

DMI and Brain Sensitivity
Shah and Lal (1971) have presented evidence that
pretreatment of mice with DMI lower5 neuronal excitability.
The evidence can be summarized as :follows;

rn-II

pretreatment:
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1.

at 2J°C ambient temperature, significantl·y poten"ti ate d
narcosis due to barbital or hexobarbital, shortened
the onset of narcosis due to barbital and produced a
significant reduction in body temperature.

However, at

30°c ambient temperature the hypothermic ef1'ect was
abolished as was the potentiation of barbital-induced
narcosis.
2.

significantly lowered the hexobarbital whole-body levels
at awakening.

3.

did not alter rate of penetration of barbital into
brain.

SOCIAL DEPRIVATION
Depriving an organism of social interactions removes
the normal stimuli obtained from group contacts and results
in changes in the behavior and physiologic responses of the
organism.
Prolonged social deprivation has been observed to
elicit intense aggression in male mice (Yen~ al., 1959).
These animals possess a heightened neuroexcitability which
manifests itself in i1yperreactivity to physical stimuli
(Kimbrell, 1967; King et al., 1955).
Physiologic alterations in socially deprived animals include a smaller adrenal weight (Valzelli and
Garrattini, 1968), higher plasma corticosterone (S :~ gg,

1969), decreased body weight (Hatch et al., 1965) and decreased turnover of brain serotonin (Gi acalone et al., 1968) .
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The levels of' brain GABA in the dog have also been correlated with social deprivation (Agrawal et al., l967) .

Social Deprivation and Brain Sensitivity
Baumel et al.

(1970) have presented evidence that

prolonged social deprivation of' mice raised arousal levels
such that their susceptibility to CNS depressants was reduced.

The evidence can be summarized as follows;

social

deprivation of' mice f'or 5 weeks:
1.

significantly reduced duration of' narcosis due to
barbital, pentobarbital or hexobarbital but did not
alter onset of' barbital-induced narcosis, suggesting
that the permeability of' drugs into the CNS was not
changed.

2.

~ignificantly

increased hexobarbital whole-body levels

at awakening.

DRUG WITHDRAWAL
Barbiturate
The chronic administration of' barbiturates has been
reported i;o produce tolerance and phys i cal dependE•r:.ce in
humans (Isbell 1 1950) and in common laboratory animals
(Crossland and Lecnard, 1963; Essig, 1966; Norton, 1970;
Jaffe and Sharpless, 1965).
Abrupt disconti.nuation of' barbiturates, subseql.<ent
to its chronic administration in large doses, resulted in
spontaneous tonic-clonic convulsions in rats (Essig, 1966).
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The abstinence convulsions, a reliable index of the barbiturate abstinence syndrome, have been reproduced in several
animal species ( Es sig, 1967).

Wahlstrom (1971) reported

that chronic barbital administration and withdra·K al increased the hexobarbital thresholds ("the quantity of
intravenously infused hexobarbital needed to produce a
burst suppression of 1 second or more in the EEG") in rats
by more than

45% as compared to a pre-experimental average.

Since the aforementioned thresholds were not influenced by
an increase in metabolism (Wahlstrom, 1968), the data suggest that an alt9ration in neuronal sensitivity to barbiturates had taken place.
Since levels of brain GABA have been COITelated with
convulsions under a variety of conditions (Essig, 1968) ,
suggested that the convulsions induced by barbiturate withdrawal could be due to reduction in brain leveJ.s of GABA.
This was

furt~er

supported by the fact that amino-oxyacetic

acid (AOAA), a compom1d known to elevate brain GABA
(Wallach, ~961), protected rats and dogs against barbi turate
withdrawal induced convulsions (Essig, 1968).

Alcohol ( Ethanol)
Chronic administration of alcohol has be en reported
to produce tolerance and

phy~ical

dependence in humans

(Isbell et al., 1955) and in common laborat ory animals
(Goldstein and Pal, 1971; Freund, 1969; Essig and Lam, 1968).
Abrupt alcohol withdrawal after chronic administ:ra-

24

tion has b::?en shown to result in a typical abstinence syndrome, which is characterized by tremors, generalized
tonic-clonic convulsions and a lowering of the threshold for
electroconvulsive seizures (Freund, 1969; Essig and Lam,
1968; McQuarrie and Fingl, 1958).

Freund and Walker (1971)

found that C57BL/6J mice, a strain genetically resistant to
the induction of audiogenic seizures, could become highly
susce9tible to audiogenic seizures upon abrupt withdrawal of
ethanol after its chronic administration.

Several hypotheses

have been proposed to explain the mechanism of convulsions
occurring during withdrawal from addictive drugs (Mendelson,
1970).
Animal models for alcohol dependence have only very
recently been developed.

Essig and Lam (1968), Ellis and

Pick {1969) and Freund {1969) have shown that development
of physical dependence in animals is a

surpri~ingly

rapid

process, as compared with the slow progress of alcoholism
in man.

The shortest reported times :for producing withdraw-

al reactions are about 2 weeks in dogs and monkeys and I+
days in mice.

The recent report by Goldstein and Pal ( 1971)

indicqte that, it is possible to produce alcohol dependence
in mice by maintaining intoxicating blood levels
for two days.

o~

ethanol

They used pyrazole, an in11.ibi tor of alcohol

elimination in vivq_, and housed animals in an atmospher e of
ethanol vapour.
The assumed role of GABA as an inhibitory transmitter
has elicited interest in possible effects of ethanol on

25

levels and metabolisr.1

ot~

GABA.

Ethanol has been repor-ced to

raise the concentration of GABA, glutamate and aspartate,
and to decrease glutamine, in the brains of rats in vivo

---

(Hakkinen ans Kulonen, 1961) and electrically stimula ~n d
cerebral cortex tissue in vitro (Hakkinen et al., 1963).

An

acute intoxicating dose of ethanol, to rats, has been reported to decrease the concentration of' GABA in cerebral
hemispheres and in cerebellum (Gorden, 1967).

In the brains

of rats given 15% alcohol as sole fluid for 23 days, bol.LLd
GABA was slightly lowered whereas free GABA was not changed
(Hagen, 1967).

Alcohol and Pvrazole
Pyrazole inhibits the metabolism of ethan.::>l both in
vitro and in vivo.

In 1963, Theorell and Yonetani reported

that pyrazole inhibited liver alcohol dehydrogenase by
formation of a ternary com;>lex with ADH and nicotinamideadenine dinucleotide (NAD).

Lester .et a l.

(1968) and

Goldberg and Rydberg (1969) showed that pyrazole inhibited
ethanol metabolism in rats as evidenced by th e persistence
of high blood alcohol concentrations.

In the former si::udy,

it was reported that pyrazole and li·-subs tituted pyrazoles
inhibited ethanol metabolism, while substitution in any
other position did not produce a similar inhibition.

More

recently, two investigations (Bustos et al., 1970; Morgan
and DiLuzio, 1970) appeared which dealt with the induction
of fatty livers in animals treated with pyrazole-ethanol.
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Although the principal findings of these studies were distinctly controversial, the investigators were in agreement
with regard to one important observation:

the concentrations

of blood ethanol in rats treated with pyrazole-ethanol persisted at a hi gh level for as long as 16-20 hr, thus indicating a pyrazole-induced inhibition of ethanol metabolism.
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EXPERIMENTAL
Animals:
Swiss albino, random bred male mice weighing 25-35 g
and Sprague-Dawley albino, rando'm bred male rats (Charles
River Farms, Wilmington, Mass.) weighing 150-200 g were
used.

They were housed in animal quarters maintained at

21-2J°C with room lights alternated on a 12h light-dark
cycle.

Food and water were available ad libitum up to one

hour before each experiment.

Animals were used not earlier

than one week after receipt from the supplier.
Materials:
Analytical reagent grade chemicals or equivalent
were used throughout the study.

Co-factors were purchased

from P-L Biochemicals Inc., :MihV"aukee, Wisc.

The drugs

and the enzymes used in this investigation were obtained
from their respective manufacturers.
HyPobaric Chambers:
The hypobaric chambers (Figure 2) utilized room air
and consis~ed of four plexiglass desiccators (Internal diameter 10'', height 14", Ace Glass Inc. ) connected j_n parallel via 1/2" rubber tubing to a vacuum pump (1/2 h.p.,
Gelman Instruments ) through a manifold consisting
copper pipe.

,,

01'

l/L~"

The degree and rate of reduction in ambient

pressure within the chambers was contro ll ed by a cent.ral
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needle valve attached to the air intake manifold.

The baro-

metric pressure within the system was monitored by vacuum
gauges on individual chambers and mercury manometer attached
to the end chamber.

Separate needle valves placed along the

system permitted recompression of individual chambers independent of the other units.
Decreasing barometric pressure within the chambers to
364 mm Hg (p0 =76 nun Hg, equivalent to a 10% oxygen atmos2
phere at sea level) resulted in room air entering the system at approximately 9 liters/min which ~as assumed to be
adequate for continuous removal of expired carbon dioxide,
and prevention of excess moisture condensation within the
chambers.

Under these conditions, the temperature within

the chambers was maintained within 1° of the ambient ternperature.
Exposure to Hypoxia:
The animals were placed, in pairs, in each of the four
chambers which were then decompressed in a 10 minute period
to 364 mm Hg (p0 =76 mm Hg, equivalent to a 10% oxygen at2
mosphere at sea level). Control mice were run concurrently
in identical chambers open to room air.

One group of mice

was exposed continually to hypobaric hypoxia for JO minutes
and the other group was exposed for 60 minutes.

The animals

were then removed from the hypoxia chambers at the end o f JO
or 60 minutes and were immediat ely frozen in liquid nitro g en.
The experiment s were done at 22 and J0 ° C ambient tempe r ature
in a constant temperatur e environmental chamber.
Brai n Lesioning :
Bilateral electrolytic lesions were produc e d in
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175-200 g male albino rats of the Sprague-Dawley stra in , by
means of David Kopf stereotaxic apparatus.
that of Zuromski ~al.

(1972).

The method wa s

The subjects ·...-ere anaesthe-

tized with Nembutal (40 mg/kg) supplemented by local application of Xylocaine.

Bilateral septa! lesions were produc e d

using 2 ma anodal current for 20 sec through the llllinsulated
tip of a stainless-steel pin.

The stereotaxic j_nstrument

with a modified head-holder which held the head level was
used to position the electrode, 1.0 mm anterior to bregrna,
2.5 mm lateral from r,he midline, _5.5 nm1 deep (:from t11e sP. rface of the cortex), and 25° tow-ard. the midline.

Sham-

operated controls and normal cont rols were also included.
In the sham-operation the animal was anaesthe tiz e d, placed
in the stereotaxic apparatus and t he skull dril le d but dura
spared.

All animals were given 25,000 units of procaine

penicillin post-operatively.

All animals were housed indi-

vidually immediately after the operation and then housed
two per cage on the seventh postoperative day
nation of the experiment.

u...~til

termi-

Barbital induced narcosis was

measured in order to confirm location of the septa! lesions
(see Harvey et al. 1964).
Measurement of Drug-Induced

~rcosis:

Duration of narcosis was taken as the interval between the loss and the regain of righting reflex, the end
point of which was determined according to Wenzel and Lal

(1959) using two rightings wi t hin JO s e conds.

The interv a l

between injection of the drug and loss of' ri ghtin g r e fl e x
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was designa t ed as onset of narcosis (induc t ion time).

Ba r bi -

tal was injected intraperitoneally as the sodium salt in
distilled water.

Determination of duration of barbi t al na.r-

cosis and induction time were done as described above.
Social Deprivation:
Mice weighing 18-20 gm were housed either l
or 10 to a cage in stainless steel cages
with wire mesh on fronts and bottoms.

(9.5 11

x

to a cage

7"

x

7 11 )

Solid walls on the

remaining 3 sides reduced visual or tactile contacts of the
isolated mice with other animals.

Animals were not handled

or removed from their cages during the deprivation period
but were kept clean by changing the bottom pans regularly.
The mice ·were subject to all daily noises of the animal
room.

Ambient temperature was maintained at 21-2J°C and

room lights alternated on a 12h light-dark cycle.
Chronic Ph e nob arbit a l Administration and Withdra wal:
The fluid intake of mice was restricted to incre a sing concentrations of phenobarbital in drinking water.
Their initi a l dose was 50 mg/kg/day and was increased weekly until they received 400 mg/kg/day. Phenobarbital solution also contained 0.2 mg/ml saccharin to mask the bitt e r
taste of the barbiturate.

Control animals received 0. 2

mg/ml of s ac charin in drinking water :for four weeks.

'Th i s

method was ori g i n ally r ep orted by Crossland and Leonard

(196 3 ).
Duri n g t ha exp e rirne:it six mice were hous ed per c ag e.
Fresh phenobarb i t al so l ut i on (100 ml) was g i v en e v ery d ay
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and total amount of' the solution consumed by a group of six
animals per day was recorded during the entire period of
four weeks.
At the end of four ·weeks of phenobarbital, the drug
administration was discontinued.
drinking water only.

The animals were given

After 24 hours, eight randomly se-

lected experimental animals were exposed to an auditory
stimulus (100 dB for JO seconds).

Mice showing convulsions

within JO seconds were immediately frozen in liquid nitroge n
and were stored at -40°C.

The same procedure

w~s

followed

for 48 and 120 hour withdra1n1 animals except that, some of
the 48 hour and all of the 120 hour withdrawn animals did
not exhibit any CNS hyperexcitability (convulsions).
ther, a group

o!~

Fur-

24 hour wi thctrawn 2,nimal:: we.•.:=; sacri :':L ced

without any prior exposure to the auditory stimulus.

Con-

trol animals were exposed to the stimulus for JO seconds
before

sac~ifice.

Ethanol Vapour-Chamber:
The ethanol vapour-chamber (Figure J) consisted of'
a flat bottom, cylindrical glass jar placed horizontally
on a wooden platform.

It contained a perforated floor,

drinking water and food pelle ts .

The open end of the jar

was clo s ed by a wooden frame with a circular window (5" diameter) for the introduction of the animals and was fitted
with a rubber stopper (2" diameter) having four holes.

The

rubber stopper was fitted with t·Ko inlets (one for air a::ld
the other one foy ethanol) and outlet tubing5 and a thermom-

33

r

34

et er .

Air and alcohol inflows

w~re

regulated by t;rn

separa-:;~

flow meters (Hoke Inc., Cresskill, N .J.).
Determination of Ethanol Vapour-Concentration :
The enzymatic method o .f Lundq<Ji.st (1959) was used f0r
the dete rmination .

A sample of chamber air , l

ml ,

;..•a s

with -

drawn in Hamilton air-tight syringe (Hamilton Company Inc. ,
Cal.).

The air sample was then injected througr. . the e.i r -

tight rubber cork into the head

spa~e

5 m1 (. .,.J, • uR m1 b u ff er + C • 1 m_1 enzyrne +

of a vial containing
0~

.

1 rn,_,_ N
_..AD·
. ·)

reaction mixture used for the determination of
blood.

"~
~ -

•n°
~ . . :...

e~h~nol

in

The re action was allowed to proceed for 60 min at

room temperature and the absorption was measured at J40 rau .
The optic al cl ·::.' ..: i ty, after subtraction of a blaP..k value (1
ml

O -f' .

ro on·' <:>-·• .;...
-:1' ·,J

'

·-a
·· used in t he following formula to get
.~ . :::>

mg of e thanol/liter of chamber air.
Sample OD

s~andard 0Dl2mg/ml)

X 39
_
.
·2-mg ethanol/liter of chamber
air

The standard analysis was made by a dditicn of 100 ul
of the ethanol standard soluti on cont aining 1, 1.5 and 2 mg
of ethanol per ml of

distill~d

water .

Figure

4

demonstrates

the relationship be~ween air flow (liters/oinute) and chamber air-ethanol concentration (mg/liter) •
.....--/
Df~termina t io r.

of Blood

EthC!-_nol - level~ :

The ass ay ::_)·rocedure was that of Lundquist (1 959) .
Mice ·we re removed from the chamber and \·.r ere sacrificed by
cervical dislocation.

Ab~ut

150 ul blood 1>'a s withdrawi:1 :from
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Figure 4.
RELATIONSHIP BETWEEN AIR-FLOW (liters/min) AND
CHAMBER AIR-ETHANOL CONCENTRATION (mg/liter). An airethanol mixture was obtained by mixing two streams of air:
one directly to the chamber at a rate of 2.5, 5 or 10
liters/min and the other bubbling through absolute ethanol.
(Reagent Quality, u.s.P.) contained in a glass jar to the
chamber at a flow rate of 0.75 liters/min (which was kept
constant).
Each point represents the mean + S.E. of
three determinations.

36

the heart with a tuberculin syringe.

The sample containing

100 ul of blood was then deprotenized by means of perchloric
acid

(4

volume,

3.4%).

The supernatant obtained after cen-

trifugation at 2500 rpm for 10 min was used directly for
analysis.

The supernatant (100 ' 1) was added to l~ .8 ml of
1

a buffer contai ning pyI:ophosphat~ and .semicarbzide

8.6-8.7,

together with lOOul of

1.3%

NAD

2

1

at pH

so.l.ution.

The

enzymatic reaction was started by addition of 50 ul of
crystalli.ne yeast alcohol deh.ydrogenase suspension. 3

Tne

reaction was allowed to proceed for 60 min at room temperature and the a.bsorption

'~as

measured at

340

mu.

The optical

density, after subtraction of a non-e thanol blank valw-) ,
was proportior.al to the concentration of ethyl alcohol 5_n
blood.

The standard analysis was made by addition of 100

ul of absolute ethanol standard solution containing l, 1.5,
2 and 2. 5 mg of ethanol per ml of' d.istilled water.

Fig·ure

5 demonstrates the standard curve for quantitative determination of' ethanol by the enzymatic method of Lundquist

(1959).
1

2

Prepared by dissolving 10 g of' sodiuJn pyrop:10sphate, 2.5 g
of semicarbazide hydrochloride, 0.5 g of' g l ycine and 10 ml
of 2N NaOH in sufficient water.
The final volume was adjusted to JOO ml with distilled water and 'the pH was a djusted to 8.6-8.7.
Nicotinaruide-ad enine dinucleotide.

3 30 mg of' +. he enzyme '-ms suspended in 1 ml o:f satura ted
solution of ammonium sulfate.
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Figl,lre 5.
STANDARD CURVE FOR QUA.i~TITATIVE DETER.i"IINATION
OF ETHANOL IN BLOOD. The enzymatic method of Lundquist
(1959) was used. Pure yeast alcohol dehydrogenase (JO
mg/ml), 0.05 ml, and l.J% NAD (0.1 ml) ~as added to the
e~h~nol solution containing semicarbazide -glycine buffer,
P.If..: 896-8.7. After 60 minutes at room temperature the
mixtures were read at J40 mu.
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Chronic Ethanol Intoxication and Withdrawal:
The animals were exposed con'tjnually for 96 hours in
the ethanol vapour-chamber (Figure J) to an . air-ethanol mixture obtained by mixing two streams of air:

One directly to

the chamber at a rate of 5 liters/minute and the other bubbling through absolute ethyl a]_cohol (u. S. P.) c vntained in
a glass jar to the chamber at a flow rate of· O. 75 liters/
minute.

With the10e flow rat as the chamber air-e'thanol con1

centration re~ained at 10 mg/li~er (Fig~re
were removed from the chamber twice a d ay

4).
:f~r

The mice
about 25 m=.:. n-

utes in order to weigh them and to inject pyrazole (once
daily).

Pyrazole ;..· as given to obtain stable blood ethanol

levels; it has been shown to icl1ibit the metabolism of
ethanol both in vitro and in vivo (Theorell et al., 1969).
The dose of pyrazole we used was, O • .5mrno .l e/kg ( Jli· mg/kg),
i.p., given at O, 24,

48 , and 78 hours during the exposure

of mice to an air e'thanol mix'ture.
The chamber air-e'thanol concentration (10 mg/li'te:r) ,
and the daily dose of pyrazole (0.5 mmole/kg) mainta14ed
the blood alcohol-levels of mice at 1.5 to 1.9 mg/ml for
four days (Figure

6) .

The mice were removed from the ethanol vapour-chamber 24 hours after their last dose (at 72 hours) of pyrazole.
They were then ob=erved almost continually for 12 hours,
with scores of abstinence synd.rome recorded hourly .
Measurement of Gamma-A.minobutyric Acid :
The assay procedure ·Kas that o:f Graham and Aprison
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Figure 6.
BLOOD ETHANOL CONCENTRATIONS DURING EXPOSURE
TO ETHA1 0L VAPOUR. Each point repres e nts tha average
blood ethanol-levels of two mice.
The y were exposed to
ethanol vapour concentration of 10 mg/liter for 96 hours.
Pyrazole (0.5 mmole/kg) was injected at O, 24, 48 and 72
hours.
Blood samples were taken for ethanol assay each
afternoon be1~ore pyrazole was injec t ed. f indicate withdrawal (removal of the animals from the chamber) • .,_ ___ __
blood ethanol-levels dropped to 0.24 mg/ml in about 5
hours after withdrawal.
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(1966).

Whole mouse or rat heads were f'rozen in liquid n.i-

trogen and kept at

-4o 0 c for 20-24 hours.

At the time of

assay whole brains were rapidly removed (within 45 seconds),
weighed and homogenized: a) a mouse brain in 20 volumes of
ice-cold 75% (v/v) ethanol or b) a rat brc.in irL ~ volumes
of ice-cold 75% ethanol.

Samples were then ce ntrifuged at

5000 rpm at 0°C for 15 minutes.

The superuates were re-

moved and stored at 4°C while the pellet was resuspended in
20 voltune (for a mouse brain) or 4 volume (for

rat brain)

a

of ice-cold 75% ethanol and centrifuged as above.

Both

supernate fractions were then combined and mixed tl1oroughly.
Two ml samples (from a mouse brain superna~e) or o .4 ml
samples (from a rat brain supernat.:i) were added to sample
vials and evaporated to dryness at 60°C in a >·rater bath with
constant air flow into each vial.
-4o~c

Samples were kept at

for 24 hours at which time G.ABA was measured.

The

contents of each vial were suspended in 5 ml of 117ate-r.
ml of sample was shaken with an equal volume of

~~.vo

chlo~of'or.:n

and centrifuged in a clinical centrifuge (Inte rna.T;iona.i
Equipment Company) at 3500 rpm for 20 minutes.
The substrate solution cCJnt:ained 1.4 ml pyrophosphc-:_i:;e
buffer
1

2

1

(0.1 M, pH

8.4), 0.2 ml NADP-? (0. 00 5 M in water),

Prepared by dissolving 4.46 g _~a?P?O -lOH 0 in 80 :n.:L water.
Norit-A was added and the sollnion-sfirrea for 15 min a .fr.er
which the solution was filtered through Celite .
The pH was
adjusted to 8.4 with lN HCL and -the -..olume a.dju ste d to 100
ml.
The buffer Ka s stored in an amber bottle a;; !.i.°C ali.G
was prepared fresh 24 hour prior t o each assay.
Nicotinamide-adenine dinucleotide phosphate.
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O. 2 ml alpha-keotglutaric acid ( O. l M in bu 1~ f er), 0. 2 ml
mercaptoethanol (0.06 M in buffer) and 10 mg GABase enzyme.
Incubation mixtures contained O.l ml b r ain sample, standa rd
or water; O.l ml pyrophosphate buffer and 0.04 ml substrate
solution.

Tissue blanks were prepared in the same ma nner

except that no GABase was added.

Incubations were for 45

min at J7°C in a Dubnoff metabolic shaker.

After incubation,

0.2 ml alkaline phosphate 1 was added to the tubes and mixed
thoroughly.

Tubes were heated at 60°C for 15 min, then

0.2 ml Na0H-H 2 o2 2 was added, mixed thoroughly and the tubes
were heated 60°C for 10 min.

One ml of water was added to

the tubes and the contents were mixed

~horoughly

and the

fluorescence read immediately in an Aminco-Bowman spectrophotofluorometer (excitation at 360 mu ar.d emission at 460
mu, sensitivity setting at 50 and slit width of 1/64 in).
Values were reported as umoles GABA/g brain (wet weight).
Measurement of Glutamic Acid Decarboxv lase Activi_!.Y::
The assay procedure was that of Roberts and Simonsen
(1963).

The C-14-L-glutamic acid substrate solution was

made by combining 1 ml of 1-C-14-L-glutamic acid (25 micro
Ci), 25 ml of 0.2M L-glutamic acid

-adjusted to pH 6.5 wi th

KOH, 10 ml of 5 per cent (v/v) Triton X-100, J6 ml of

o. 4M

1 Prepared by dissolving 15.2 g NaJPo -12H 0 and 2.6~ g
2
4
Na HP01 in sufficient water to ma ke 100 ml.
Solution was
2
stored.:+in amber bottle at room temperature.
2

~repared fresh just prior to use by adding 0.2 ml
H o to 10 ml of lON NaOH.
2 2

3%
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potassium phosphate buffer 1 (pH 6 .5) antl 5 mg pyridoxal
phosphate.

This solution was adjusted to a final volume of

100 ml with 0.2M potassium phosphate buffer 2 (pH 6.5).

The

solution was 5 x l0- 2 M in l-C-14 glutamate (sp. act. 1.25
uc/umole), 2 x l0- 4 M in pyridoxal phosphate, 0.5 per cent
in Triton X-100 and 0. 2M in phosphate.

The final pH was

6.5 and the mixture was stored in 25 ml portions at -40°C
until use.
The procedure for collection of brain samples was as
described in the GABA-T assay except that brains ,.;ere hornogenized in

7 vol of ice-cold deionized water.

One ml of

homogenate was added to a scintillation vial that was used
as an incubation flask and one ml of Hyamine lO-X was added
to another vial.

The unit3 ,,·as assembled and the homogenates

were preincubated at J7°C for 10 min during which time each
flask was flushed with 100 per cent nitrogen for 2 min.

The

reaction was started by the addition of one ml of subsc;ra:te
l

Prepared by adding 0.4 dibasic potassium phosphate to 0.4
M monobasic potassium phosphate until pH 6.5 was reached.

2 Prepared by adding 0.2 M dibasic potassium phosphate to
0.2 M monobasic potassium phosphate until a pH of 6.5 was
reached.
3The unit consisted of 2 counting vials connected by a glass
U tube (l/4 in I. D.). The vials and U tube were connected
by means of 1/2 in lengths of high pressure tubing (soft
rubber -- l/4 in I.D., 5/8 in O.D.). Two needles (23
gauge, l in) per u,.~it ~ere inserted through the tubing and
removed after addition of C-14 sub s trate.
Sulfuric acid
was introduced through the t ubing by means of a needle and
syringe at the end o f the incubation period.
During preincubation and after nitrogen flush, needles were stoppere d
with 1/8 in O.D. glass tubing sealed at both ends.
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solution (warmed to 37°c) by means of a hypodermic syr inge .
The needles were immediately removed to seal the unit and
the samples were incubated at J7°C in a Dubnoff metabolic
shaker.
At the end of exactly 15 mi n, 0.2 cc of 4N sulfuric
acid was added to stop the reaction. The uni ts ,.;ere allo·wed
to shake for another 60 min to insure complete absorption
of the C-14-0

2

by Hyamine (10-X).

The counting vial was

1
detached and 10 ml of scintillation solution was added.
Radioactivity was counted in a Packard Tri -Carb liquid
scintillation 5pectrometer (25 per cent gain setting). Internal standards of C-14 toluene (New England Nucle ar) were
added to every other sample for determination of per cent
efficiency.

All samples were counted for 10 min.

were reported as urnoles

co 2 /gm

..

Values

brain/hr.

Measurement of GaITlffia-Aminobut ·vric Acid Transaminase Ac ti Yi ty
The GABA-T assay procedure was that of Salvador and
Albers (1959).

Brains were removed rapidly with the aid

of other investigators, weighed and homogenized in three
vol· ice-cold 1.25 per cent Triton X-100.
alpha-KG
1

2

2

mixture '"as a.djed to

o. 2

Five ml of' GABA-

ml of homog13nate..

One-

Prepared by dissolving 1 g POPOP (1,4-bis 2·-(5-phenyl oxazolyl) benzene) and O.l g PPO \s,5 diphenyloxazole)
in sufficient toluene to make l liter.
Prepared by dissol ·ing 2.575 €GABA 1nd 1.46 g
-KG ir. 50
ml water.
The pH wa~ brought t o 8 .4 with 5N· NaOH and the volume adjusted to 100 ml with water. This mixture was
prepared fresh daily and was 0.25M GABA and O.lM ir. -KG.
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half ml samples of this mixture were added to 0.5 ml of DAB
reagent 1 ( Salganic off and DeRobertis, _1 965) and stored on
ice for use as tissue blanks.

The removal of brains,

weighing and homogenization proced-ures took no longer than
45 min. for 20 mice.

The succinic semialdehyde standard was prepared ac-cording to Prescott and Waelsch ( l'.)46).

T"'·enty mg n.inhydrin

was mixed with 1.4 ml glutamic acid solution (0.001 g/ml in
0.5N acetic acid) after which time 2 . 6 ml. of 0.5N acetic
acid was added.

Reagent blanks contained

acetic acid and 20 mg ninhydrin.

4 ml of 0.5N

Reagent blanks and stand -

ards were placed in boiling water f'or 10 min .
tubes were cooled in ice, the

f~ollowing

Af-t er the

reagents were added

at 5 min intervals: o.4 ml guanidine carboca~e (14 per cent
in water), 1 ml lead acetate (12 per csnt in wat er prepared
fresh each day), 0.5 ml of 5N NaOH a.nd 0.1 ml water.

Tubes

were centrifuged at J,000 rpm for 10 min in a clinical
centrifuge.

After centrifnr;a i:;.i.on , O. 5 ml aliquots of -:·e··

agent blank and

star.~ dard

were added to

o. 5

ml of DAB re-

agent, mixed and stored on ice.
The

GABA- ~-KG

mixture containing brain homogenate

was incubated in a Dubnoff' metabolic shaker under room air
at J7°C for 60 min.

Arter incubation, 0 .5 ml aliquots

were added to 0.5 ml DAB reagent.
1

~repared by dissolving 2.8 g J.5 diaminobensoic acid HCl
in 25 ml lM potassiwn phosphate buffar (pH 5.9) (1 vol of
lM K HoP plus 9 vol of HI KH PO ) • The pH --;.;as broug~1t to
4 5N NaOH and adjusted 2 to a final volume o f 50 ml
2
5.9 with
with phosphate buffer .

Samples, tissue blanks, reagent blanks and standards
were heated at 6o 0 c for 60 min.

Nine ml water was added to

each tube and tubes were centrifuged at J,000 rpm for 10
min.

Forty ul of supernatant was mixed with 10 ml water and

samples were read in an Aminco-Bowman spectrophotofluorometer
(excitation 405 mu, emission 505 mu, sensitivity setting
at 50 and slit width of 1/64 in).

Values were reported as

umoles succinic semialdehyde/gm brain/hr.
Determination of Brain Protein
The assay method was that of Lowry et al.

(1951).

Brains were removed rapidly, weighed and homogenized in 9
vol of isotonic (1.15%) KCl.

A o.4 ml aliquot of the super-

nate, obtained after centrifugation of the whole homogenate
at 10,000 rpm for 20 min, was added to l.6 ml of 0.5N NaOH.
The test tubes were then placed in a boiling water bath to
hasten dissolution.

Following one hour in the water bath,

a 0.2 ml of the diluted sample was added to 1 ml of 0.5N
1
NaOH.
To this was added 5 ml of reagent A and mixed for

10 seconds.

Twenty minutes subsequent to the last addition,

0.5 ml of a commercial Folin-Phenol reagent (diluted to lN
with distilled water) was mixed with the sample.

The sample

was allowed to stand at a room tempera t ure for 40 minutes.
The intensity of the blue color was read at 500 mu. A blank
prepared using 1.15% KCl and was treated as the other samples.
Bovine serum albumin was used as a standard.
l

Reagent A: 1.0 ml of 1% aqueous Cuso 4 , 1.0 ml of 2.7%
aqueous potassium tartrate added to 100 ml of 2% aqueous
Na co •
2 3
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Statistical

1ethods:

The student "t" test f'or independent means, Chisquare 2 x 2 contingency analysis (Dixon and Massey, 1969)
were used to test f'or dif'f'erences between control and experimental groups.

Correlation coefficients were calcu-

lated using linear regression analysis (Dixon and Massey,

1969).

The results were also analyzed by the analysis of'

variance using a mixed-ef'f'ects model (Dixon and Massey,

1969).
Tests were performed on an Olivetti Underwood
Programma 101 desk computer and IB:H computer J60/50.

The

exact level of' significance was determined f'rom the respective standard tables.
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RESULTS
In order to determine the relationship bet·ween alteration in CNS sensitivity to

barbitura~es

and changes in

brain GABA levels we altered the CNS sensitivity of' the:
animals to barbiturates by utilizing the following lrJlown
conditions:
A)

exposure to hypobaric hypoxia

B)

septal lesions

C)

treatment with drugs, desipramine (DMI), sodium
nitrite or pargyline

D)

social deprivation

E)

abrupt withdrawal following chronic barbiturate or
alcohol administration.

The brain BABA-levels were determined after the
above treatments.
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A.

ACUTE HYPOXIA
Since acute hypobaric hypoxia, 364 mm Hg (p0 2 =76 mm Hg)

has been reported to alter the brain sensitivity of mice to
barbiturates (Baurnel et al., 1970b), we used the similar hypoxic

~xposure

in our study.

Further, the magnitude of al-

teration in brain sensitivity differed at 22°C and at J0°C
ambient temperature (Baurnel, 1970).

Therefore, we measured

brain gamma-aminobutyric acid at both 22°c and J0°C ambient
temperature.
1.

Effect of Hvpoxia on

BraL~

Gamma-aminobutyric Acid

Table 1 summarizes the effect of acute exposure to
hypobaric hypoxia (364 mm Hg, p0 =76 mm Hg) on mouse brain
2
GABA-levels.

The brain GABA-levels were markedly elevated ·

under the hypobaric environment, during both JO and 60 minute exposures.

However, the magnitude of increase in brain

GABA differed at 22°C and J0°C ambient temperature.

The hy-

poxic exposure for JO or 60 minutes at 22°C ambient temper- ·
ature caused 49 and 54% increase in brain GABA-levels, while
hypoxic exposure at J0°C ambient tempera ture produced only
29 and 40% increase in brain GABA concentrations, respectively.
The analysis of variance summarized in Table 1 shows
the effect o f' three factors, name ly, hypox ia, hypoxia duration, and ambient temperature , a nd their interactions on
brain

GABA- ~e vels.

It can be seen tha t only hypoxia had

a sig nifica n t effect on brain GABA, while hypoxia duration
and ambient t emperature had no s ignificant interaction wi t h

TABLE 1
EFFECT OF HYPOBARIC HYPOXIA ON MOUSE BRAIN LEVELS OF GAMMAAMINOBUTYRIC ACID AT TWO AMBIENT TEMPERATURES

Hypoxia
Duration
(min)

u.moles GABA/g brain
mean + S.E. (N)
Control 2
Hypoxic 1

Ambient
Temp.
( oc)

JO

60

a

%
.Change

22

2.18+0.02 (7)

J.2J.±,0.19

(7)
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JO

2.J6+0.22 (8)

J.05+0.10b (8)

29

22

2.14.±,0.10 (8)

3.29.±,0.lOa (8)
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JO

2.25+0.12 (8)

3.16.±,0.12a ( 8)

40.

Analysis of Variance
Source

p

df

MS

F

Hypoxia Duration (D)

1

0.0008

0.005

> 0.05

Ambient Temp.

1

0.0004

0.003

>0.05

91.J70

< o. 001

(T)

Hypoxia (H)

1

DxT

1

0.0004

0.003

>0.05

DxH

1

0.1056

0.007

>0.05

TxH

1

0.0150

0.001

>0.05

DxTxH

1

0.3751

0.094

>0.05

Error

22.

0.1585

14.516

63

1.

364 nun Hg, p0 2 =76 mm Hg (equivalent to a 10% oxygen
atmosphere at sea level).

2.

Controls were run concurrently in identical chambers
open to room air.

Control vs. hypobaric;
a
b

p(0.001
p<0.01
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the effect of hypoxia on brain GABA.
B.

SEPTAL LESIONS
Heller et al.

(1960) found that lesions in the septal

area in rats caused a J-fold increase in barbital-induced
narcosis, as compared with normal controls.

This effect was

found to be specific to the septal region (see Harvey~ aJ . • ,

1964).

Considering this, we measured barbital induced nar-

cosis in septal rats at first, to make sure that the lesions
were in the septal area, and then

de~ermined

the brain

levels of GABA.

1.

Effect of Septal Lesions on Barbital Induced - Narco s is
and Brain Gamma-a.minobutyric Acid
The testing of septal rats with barbital was done on

the 25th postoperative dayft
Table 2 .

The results are summarized in

Bilateral lesions of the septal area produced

marked increase in barbital induced-narcosis and decrease
in onset of' narcosis.

The brain levels of' GABA in the same

septal rats were determined on the J5th postoperative da) ·.
Duty summarized in Table 2 show that there -.es no significant difference in the levels of brain GABA between the
septal rats and sham-oparated or normal control rats.

C.

DRUG TREATMENTS
One hour pretreatment with DMI (Shah and Lal, 1971)

or half hour pretreatment ,,-i th sodimn nitrite (Baumel e t al.,

1971) have been reported to alter the neuronal sensitivity

TABLE 2
EFFECT OF SEPTAL LESIONS ON BARBITAL NARCOSIS AND BRAIN LEVELS
OF GAMMA-AMINOBUTYRIC .A:CID IN RATS
I

Experimental
Groups

umoles GABA 4 /g brain

1
Barbita1 Narcosis
Min. ± S.E. (N)
Onset

Mean ± S.E. (N)

Duration

Normal Controls

76.0± 8.1

Sham Operated 2

77.8±10.6a (6)

1Jl.8±19.7a (6)

2.4o+o.o8a (8)

Septa1 3

Jl.5± 7.1b (6)

J21.6±J6.7b (6)

2.5J+0.10c (7)

(6)

98.1±12.J

( 6)

2.JJ±0.08

( 8)

1.
2.

160 mg/kg injected intraperitoneally.
Rats with drilled skulls, but intact dura.

J.

Rats with bilateral stereotoxically placed electrolytic lesions in the
septal area of the basal telencephalon.

4.

Rat heads were frozen in liquid nitrogen prior to the measurement of GABA
in the brain.

Normal controls vs. Sham-operated.
ap

<o. 05

Normal con~rols or sham-operated vs. Septal.
bp ( o. 001
cp >0•05

V1
f-'
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to barbiturates, at 22°C but not at J0°C ambient temperature.
Pargyline, unlike DMI or sodium nitrite, altered the CNS
sensitivity of our animals to barbital at both 22°C and at
30°C ambient temperature (Table 6 ).

Therefore, we measured

brain levels of GABA in mice after DMI, sodium nitrite or
pargyline (100 mg/kg, two hours) pretreatment at both 22°C
and at J0°C ambient temperature, utilizing the same dosage
and the same pretreatment time as reported by the aforementioned workers.

l.

Effect 01~ Desipramine (rnn) on Brain Gamma-aminobutyric
Acid and Body Temp e ra t ure at Two Amb ie n t

'I'~ m per 2.!_:::._i~

Table J shows the effect of DMI, 50 mg/kg, i.p., on
brain G.A...BA-levels at two ambient temperatures, 22 ;)C and J0 °C.
DMI pretreatment caused a significant elevation in brain
GABA at 22°C ambient temperature.

However, the increase in

brain levels of GABA caused by DMI at 22°C was absent at
the higher ambient temperature.
The analysis of variance swmnarized in Table J s hows
the

ef1~ect

of two factors, namely, ambient temperature and

DMI, and their interaction on brain GABA-levels.

It can be

seen that both ambient temperature and DMI had a significant
effect on brain GABA.

Also, there was a significant inter-

action between ambient temperature and Dz.II for their effect
on brain levels of GABA.

These d a ta suggest that J0°C pre-

vented the increase in brain GABA caused by DMI at 22 ° C
ambient temperature. Furthermore, J0°C by itself cauE.<ed re-
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TABLE J
EFFECT OF DESIPRAMINE ON BODY TEMPERATURE AND
BRAIN LEVELS OF GANMA-AMINOBUTYRIC ACID
AT TWO AMBIENT TEMPERATURES IN MICE

Ambient
Temp.
( oc)

Mean + S.E. (N)
Control

2

Treated 1

Rectal temp.

( oc)

umoles GABA/g
brain

22

J8.l.±0.2 (7)

JO

J7.7.±0.2 (7)

J4.8.±0.Ja (7)
J7.5±0.2 b (7)

22

2.46+0.08 ( 6)

J.J8+0.14a ( 6)

JO

2.07±0.15 ( 7)

2.09±0.lJ

b

(7)

Analysis of Variance
Source

df

MS

F

p

Ambient Temp. (T)

1

5.J94

J9.18

< o. 001

DMI (D)

1

1.775

12.89

< o. 005

TxD

1

1.666

12.10

< o. 005

24
27

0.1J9

Error

1.

Desipramine (50 mg/kg) injected intraperitoneally 1
hour prior to freezing in liquid nitrogen.

2.

Distilled water (10 ml/kg) injected intraperitoneally
1 hour prior to freezing.

Control vs. Treated
a

b

p <0.005
p <0.05
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TABLE 4
EFFECT OF VARIOUS DOSES OF DESIPRAMINE ON MOUSE BRAIN LEVELS
OF G.AMMA-AMINOBUTYRIC ACID AT 22°C AMBIENT TEMPERATURE

1
DMI
(mg/kg)

umoles GABA/g Brain
mean± S.E. (N)

%

Increase

p

None 2

2.46±0.08 (i)

12.5

2.57±0.11 (6)

4

> 0.05

25

2.97.±,0.lJ (6)

20

<. 0.01

50

J.JS+o.14 (6)

37

< o. 005

100

J.75±0.11 (6)

52

< o. 001

1.

Desipramine injected intraperitoneally 1 hour prior
to freezing in liquid nitrogen.

2.

Distilled water (10 ml/kg) injected intraperitoneall y
1 hour prior to freezing.
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Figure 7. EFFECT OF VARIOUS DOSES OF DESIPRAMINE ON MOUSE
BRAIN LEVELS OF GAMMA-AMINOBUTYRIC ACID AT 22°c AMBIENT
TEMPERATURE. Desipramine was administered 60 minutes prior
to sacrifice. Each point represents the mean ± S.E. Seven
animals were used for the control and six for each dose
level. Open symbols denote significant (p<0.01) difference
from controls. P value represents rejection of the hypothesis that the correlation coefficient (r) equals zero.
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duction of brain GABA-levels in control animals as compared
to the control animals exposed at 22°C ambient temperature.
Since DMI pretreatment, at 22°C but not at J0°C ambient temperature, caused a dose-dependent hypothermia (Shah
and Lal, 1971) with an optimum at one hour, this time period
was used to investigate the effect of various doses of DMI
on brain GABA-levels.

Actual means, standard errors, levels

of significance and percent increase in brain GABA
shown in Table 4.

ai~e

Figure 7 illustrates the dose-dependent

effect of DMI on brain GABA-levels.

Til.ere was a significant

correlation (r = 0.85, p <. 0.005) between "the dose of DMI and
elevation of brain GABA.
The effect of DMI on rectal temperature of mice at
two ambient temperatures, 22° and J0°C, is described in
Table

4.

At 22°C ambient temperature, DMI caused a sig-

nificant reduction in body temperature with an optimum at
one hour.

However, hypothermia caused by DMI at 22°C was

absent at the higher ambient temperature.

Similarly, ele-

vation in brain GABA caused by DMI at 22°C was absent at
J0°C ambient

2.

te~perature.

Effect of Sodium Nitrite on Brain Gamma-aminobutyric.
Acid and Body Temperature at Two Ambient Tempera·tures
Table 5 shows the e:ff'ect of sodium ni"trite, 100 mg/

kg, i.p., on brain GABA-leve ls at two ambient tempera-cures,
22° and J0°C.At 22°C ambient temperature,

sodiu.~

caused a significant elevation in brain GABA.

nitrite

However, the
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:I'ABLE 5
..EFFECT OF SODIUM NITRITE ON BODY TEMPERATl.JRE AND
BRAIN LEVELS OF GAMMA-AMINOBUTYRIC ACID AT
TWO AMBIENT TEMPERATURES IN MICE

Mean + S.E. (N)

Ambient
Temp.
( oc)
Rectal temp.
. (oc)

umoles GABA/g
brain

Control

2

Treated

p

1

22

38.4±0.2 ( 8)

J5.J+O.J ( 8)

< 0.005

JO

37.8+0.2 (7)

37.5+0.l (7)

>0.05

22

2.51±0.17 (8)

3.JJ+0.11 (8)<0.005

JO

2.19±0.12 (7)

2.32+0.16 (7)>0.05

Analysis of Variance
p

df'

MS

F

l

3.524

18.899

Sodium Nitrite (SN)

l

1.833

9.832

<O.Ol

TxSN

l

0.966

5.180

.(0.05

Error

28
Jl

0.186

Source
Ambient Temp.

(T)

< o. 005

1.

Sodium nitrite ( 100 mg/kg )injected intraperi toneally
J O minutes prior to freezing in liquid nitrogen.

2.

Distilled water (10 ml/kg) injected intraperitoneally
JO minutes prior to freezing.

58

increase in brain GABA c a used by sodium nitrite at 22°C was
absent at the higher ambient temperature.
Data summarized in Table 5 also describes the effect
of sodium nitrite on rect a l

temperature of mice at two am-

bient temperatures, 22 ° C and J0°C.

It can be seen that so-

dium nitrite produced a significant reduction in body temperature at 22°C ambient temperature.

The peak effect on

body temperature occurred a pproximately JO minutes after
nitrite injection.

Howev er, hypothermia due to sodium ni-

trite at 22°C was prevented at J0°C ambient temperature.
Similarly, elevation in brain GABA-levels caused by sodium
nitrite at 22°C was abs c. nt at the higher ambient temperature.
The analysis of v ariance surrunarized in Table 5 show
the effect of two fac t or s , namely, ambient temperature and
sodium nitrite, and their interactions on brain GABAlevels.

It can be seen that both ambient temperature and

sodium nitrite had a significant effect on brain levels of
GABA.

Also, there was a significant interaction between

ambient temperature and sodium nitrite for their effect on
brain GABA-levels.

These data indicate that J0°C pre-

vented the increase in GABA caused by sodium nitrite at
the lower ambient temp e rature.

Furthermore J0°C by it-

self caused reduction of brain GABA-levels in control animals as compared to the control animals exposed at 22°C
ambient temperature.
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J.

Effect of Pargyline on Barbital Induced-Narcosis, Body

Temperature and Brain Gamma-Aminobutyric Acid at Two Ambient
Temperatures
At both 22°C and J0°C ambient temperature, pargyline
(100 m@/kg, i.p., 2 hr pretreatment) potentiated narcosis
induced by biologically stable barbiturate (barbital), produced hypothermia and elevated brain levels of GABA (Table

6).

These effects were statistically significant in all

cases.

However,the magnitude of the effects produced by

pargyline differed at both the ambient temperatures.

At

22°c, pargyline produced nearly 2-fold greater potentiation
of narcosis due to barbital and a 2-fold greater decrease
in rectal temperature of mice as compared to J0°C ambient
temperature.

The elevation in brain levels of GABA was

also greater at 22°C as compared to the higher ambient temperature (Table 6).
Pretreatment of mice with various doses of pargyline
at 22°c ambient temperature caused a marked reduction in
body temperature, reaching a maximum drop of J-6° with
100 mg/kg and 6.1° with 200 mg/kg dose (Figure 8).

At

J0°C ambient temperature, the drop in body temperature due
to pargyline was only one half of what was seen during
pargyline treatment at 22°C, and reached a maximum drop of
1.8° with 100 mg/kg and J.8° with 200 mg/kg dose (Figure 8).
The analysis of variance summarized in Table 6 shows
the effect of two factors, namely, ambient temperature and
pargyline, and their interaction on brain levels of GABA.
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Barbita1 3
Narcosis
(min)

II·

I\

1\ ~

+
Mean 7 S.E.

Ambient
Temp.

( oc}

. I

I ' '

Control

2

ll

1

I I

~·

I

I I ·' I i ' I l ,'o\ I I ' I ' l

{N}
Treated

'I l

I

I

%

l
a

l "

Change
(8)

102

161.± 8.7a

(8)

.58

J8.7.±.0.l (6)

J4.8.±0.5b

(6)

10

JO

JS. 4+0.• 1 ( 6)

J6.7.±0.lb

( 6)

4

umoles GABA 4 /g
22
Brain

2.2.s+o.09 (7)

2.88.±.0.lOb (7)

28

. JO

2.29+0.ll (7)

2.79.±.0.l4c (7)

21

22

129.±lJ.l

(7)

261.±1.5.0

JO

102.±11.7

( 8)

22

Rectal Temp.

( oc)

0\

0

Table 6 (Continued)
Analysis of Variance of Data on the Effect of Ambient Temperatur~ and
Pargyline on Brain Levels of Gamma-Aminobutyric Acid

Source

df

MS

F

p

> 0.05

- -·
1

0.006

0.068

Pargyline (P)

1

2.228

22.152

TxP

1

O.OJO

0.300

24

0.100

Ambient Temp.

(T)

Error

<:. o. 001

>0.05

27
1.

Pargyline (100 mg/kg) injected intraperitoneally 2 hours prior to 3 or 4.

2.

Distilled water (lO ml/kg) injected intraperitoneally 2 hours prior to J or

J.

Barbital (JOO mg/kg) injected intraperitoneally.

4.

Mice were frozen in liquid nitrogen before the determination of brain GABA.

Control vs. Treated:

a

p <.0.001

b

p

< 0.005

c

4.

p < 0.02

O'\
I-'
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TABLE 7•
EFFECT OF VARIOUS DOSES OF PARGYLINE ON MOUSE BRAIN LEVELS
OF GAMMA-AMINOBUTYRIC ACID AT 22°C AMBIENT TEMPERATURE

Pargyline
(mg/kg)

1

umoles GABA/g brain
mean ± s.E. (N)

%

increase

p

None 2

2.20±0.05 (6)

25 .:

2.32±0.12 (5)

5

50

2.64±0.09 (5)

20

< 0.005

100 _

2.90+0.12 (6)

31

< o. 001

200 :

3.08+0.13 (5)

39

<0.001

> 0.05

1.

Pargyline injected intraperitoneally 2 hours prior to
freezing in liquid nitrogen.

2.

Distilled water (10 ml/kg) injected intraperitoneally
2 _hours -prior to freezing.

·~ .~3

39

38
CJ

0

37

36
35

--0- 22• c
34

-6-30° c

32

0

25

50

100

200

PARGYLINE <rnotkg)

Figure 8. EFFECT OF PARGYLINE (mg/kg intraperitoneally)
ON RECTAL TEMPERATURE OF MICE AT TWO AMBIENT TEMPERATURES.
Pargyline was administered 120 minut es prior to the measure. ment of rectal temperature. Each po i nt represents mean
± S.E. of 6 animals. Open symbols denote significant difference (p<0.01) from saline controls.
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Figure 9. EFFECT OF VARIOUS DOSES OF PARGYLINE ON MOUSE
BRAIN LEVELS OF GAMMA-AMINOBUTYRIC ACID AT 22°C AMBIENT
TEMPERATURE. Pargyline was administered 120 minutes prior
to sacrifice. Each point represents the mean ± S.E.
Numbers in parentheses represents number of animals used.
Open symbols denote significant (p<0.05) difference from
controls. P value represents rejection of the hypothesis
that the correlation coefficient (r) equals zero.

Pargyline had a significant effect on brain GABA, while ambient temperature on pargyline and ambient temperature failed
to affect brain levels of GABA.

These data indicate that

J0°C did not prevent the increase in GABA caused by pargyline at the lower ambient temperature. Further, the higher
ambient temperature by itself failed to affect brain GABAlevels of control animals.
Since an optimum drop in body temperature was observed
120 minutes after pargyline injection, this time period was
used to investigate the effect of various doses of pargyline
on brain GABA-levels.

Actual means, standard errors, levels

of signifi cance and percent increase in brain GABA are shown
in Table 7.

Figure 9 illustrates the dose-dependent effect

of pargyline on brain GABA-levels.

There was a significant

correlation (r = 0.76, p (0.005) between the dose of pargyline and elevation of brain GABA.

D.

SOCIAL DEPRIVATION
Since prolonged social deprivation has been reported

to lower the neuronal sensitivity of mice to barbiturates
(Baumel, ~al., 1970a), we measured brain levels of GABA
following different intervals of social deprivation.

1.

Effect of Social Deprivation on Brain Gamma-amino-

butyric acid
Data summarized in Table 8 shows the effect of social deprivation on mouse brain GABA-levels.

Social

deprivation for one day or seven days did not affect brain
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TABLE 8
EFFECT OF SOCIAL DEPRIVATION OR

SOC~L

ON . MOUSE BRAIN LEVELS OF GAMMA-AMIN

Days of'

Social
Environment

60 :
150

~UTYRIC

ACID

umoles GABA/g brain
me an + S • E • ( N )
Social 2
Interaction ·

Social l
Deprivati&llllll-

%
Change

P

2.44+0.lJ (7)

2.4J±O.o6 (7)

0.4

>0.05

2.J0±0.08 (8)

2.24±0.1 5 (8)

3

~0.05

2.65+0.12 (8)

2.01±0.09 (8)

23

<0.005

2.75+0.08 (7)

2.22±0.14 (7)

20

.(0.01

2.55+0.08 (7)

2. OJ±0.11 ( 7)

20

<0.01

2.59±0.07 (8)

2.06+0.09 (8)

20

{0.005

2.61±0.16 (6)

1.99±0.14 (6)

24

<o. 02

1 • . Housed 1 to a cage.
2.

INTERACTION

Housed 10 to a cage.

TABLE .9
EFFECT OF SOCIAL DEPRIVATION OR SOCIAL INTERACTION ON MOUSE BRAIN LEVELS OF
GAMMA-AMINOBUTYRIC ACID, GLUTAMIC ACID DECARBOXYLASE,
GAMMA-AMINOBUTYRIC ACID TRANSAMINASE AND PROTEIN
Mean + S.E.
Measurement

Social
-Environment

1

GABA
umoles/g
Brain

Interaction

2.44+0.13

Deprivation

GAD
umoles co2/g
Brain/hr

Interaction
Deprivation

10.17+0.45b
10,JJ.±.0.68

Interaction

-

umoles co2/mg
Protein

Days of Social Environment
JO
7
2.J0+0.08

(8)

2.75.±.0.08

(7)

2.4J.±.0.06b (7)

2.24.±.0.15b

( 8)

2.22+0.14a

(7)

~~~

10.52.±.0.87b
10.10.±.0.96

~~~

10.47+0.77
a
7.02.±.0.80

~~~

Deprivation

-

GABA-T
umoles/g
Brain/hr

Interaction
Deprivation

Protein
mg Protein/g
Brain

Interaction

-

Deprivation

(N)

(7)

-

265
270
2Ql
230

.±.
+
+
+

19~

16
25~
18

m

227 .±. 8.4
( 7)
228 .±. 9.6b ( 7)

-

J9.4+0.0J (16)

-

J5.2.±.0.o4a(l5)

0\

--l

T~Rt~ 9 ~P~nrfnH~~~
Analysis of Variance of Data
on the Effect of Social Deprivation on
1
1
i \ll, • I \ .
i Spebif:i'.c I .Activ:fty of ' the GtutJitiiic ' Acid Decarbo~yta~e ' I
" ' '
"
'
I

If

'

I

I

I '

1\ '

I

I

\

I

I

I

I

df

Source

I

I '

I

I

I 11 1 I (

\ •

I •

I

MS

I '· •

I I

I .. '

I

I

F

p

Interaction vs. Deprived

1

15980

6.55

<0.02

Replicates

1

1596

0.65

>0.05

Interaction

1

832

0.34

>0.05

20
23

2438

Error

1.

Interaction: housed 10 to a cage; Deprivation: housed 1 to a cage.

Interacted vs. Deprived
a

p ( 0.01

c. d.

b

p

> 0.05

Represents values obtained from two separate experiments.

0\
(X)

GABA, but social deprivation for fourteen days resulted in
a significant reduction in brain GABA levels.

Furthermore,

the levels of GABA remained depressed, while there was no
further depletion in GABA, when the social deprivation was
continued for longer periods of time (Table 8).
The effect of social deprivation on the GABA synthesizing enzyme, GAD, and the GABA degrading enzyme, GABA-T,
is shown in Table 9.

The social deprivation for thirty

days resulted in a significant reduction in GAD activity
(expressed as umoles of

co 2/g

brain/hr).

The specific ac-

tivity of the enzyme (expressed as runole~

co 2 /mg

protein)

was also significantly reduced (Table 9), suggesting that
the effect was specific to the enzyme.

Thirty days of so-

cial deprivation also lowered total protein content of the
brain (Table

9).

The activity of GABA-Twas not affected

by social deprivation (Table

E.

9).

DRUG WITHDRAWAL
It is now well known that abrupt withdrawal follow-

ing chronic barbiturate (Essig and Lam, 1968) or ethanol
(Freund, 1969) administration results in a typical withdrawal syndrome.

This syndrome due to barbiturate or al-

cohol withdrawal is essentially characterized by CNS hyperexcitability, which is observed in the form of convulsions.
Barbiturate withdrawal, has previously been reported
to lower the CNS sensitivity to barbiturates (Wahlstrom,

1971).

In the present study, with the help of biologically

stable barbiturate (barbita l ), we found that alcohol with-
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drawal _also lowers the neuronal sensitivit y to barbiturates
(Table 12).

These findings suggested that barbiturate or

alcohol withdrawal induced CNS

hyperexcit a~ ility

is also

accompanied by an alteration in CNS sensi tivity to barbiturates.

Tiierefore, we measured brain GABA-levels

following barbiturates and alcohol withdrawal.

Since

barbiturate or alcohol withdrawal induced CNS hyperexcitability returns -to normal over a period of time, we also
measured

GABA-~evels

gressed ~ to .

1.

after the hyperexcita bility had re-

see if the GABA-levels were back to control values.

Barbiturate Withdrawal
Symptoms
Approximately 16-24 hours following the barbiturate

withdrawal, eight out of ten animals showed convulsions upon
exposure to an auditory stimulus (lOOdB f or JO seconds).
Control mice did not show any signs of convulsions upon
their . exposure to the stimulus.
Up9n the exposure of the withdrawn animals to the
stimulus - it was found that, most of the convulsions were
associated with loss of upright posture, and they were
generalized tonic-clonic seizures of less than a minute
duration •. . Occasionally such convulsions lacked a clonic
phase, . and infrequently a mouse would remain upright while
generalized shaking mo v ements occurred.

The last absti-

nence convulsions occurred from 42 to 48 h ours after the
barbiturate was discontinued.

TABLE 10
EFFECT OF BARBITURATE WITHDRAWAL ON MOUSE BRAIN LEVELS
OF GAMMA-AMINOBUTYRIC ACID
umoles GABA/g Brain
Me an + S • E • ( N )

Hours of 6
Withdrawal

p

Chronic Phenobarbital Treated 1
Untreated

2

ConvulsedJ

Non-Convulsed

~

24

1.78+0.09 (8)

1.72.±,0.11 (8)

1.82.±,0.08 {8)5

>0.05

48

1.6J.±,0.1J {8)

l.J4.±,0.17 (J)

l.4J+0.14 (5)

>0.05

120

2.57+0.21 {8)

2.54+0.15 {8)

>0.05

1.

The animals received phenobarbital sodium in drinking water, together with
20 mg/100 ml saccharin to mask the bitter taste of the barbiturate, in increasing doses over a period of four weeks.
The initial dose was 50 mg/kg/day
and was increased weekly until the animals rec_eived 400 mg/kg/day.
During
withdrawal mice were given plain drinking water.

2.

Untreated animals received saccharin, 20 mg/100 ml in drinking water for four
weeks.
Saccharin solution was replaced by plain drinking water when phenobarbital was withdrawn from the chronically treated animals. The animals
were then exposed an auditory stimulus {100 db for JO seconds) before freezing in liquid nitrogen.

J.

The animals showed convulsions within JO seconds of exposure the stimulus and
were then frozen immediately.

-'I
I-'

~A~~f

4.
I.

tR

~y~~rt~~~9~

Convulsions were not observed within 60 seconds of1 exposure to the
"stimulus
11
1
~fi a 1rhm~tii'.ately ' a'.f''t~r " ~hat mlce ' were ft:ozeh'. '" ' 1
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I
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I

l'
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5.

The animals were sacrificed 24 hours following the withdrawal without any
exposure the stimulus.

6.

Different withdrawal hours at which mice were frozen in liquid nitrogen.

-.J
I\)

73

2.

Effect on Brain Gamma-aminobutyric Acid
The effect of barbiturate withdrawal on mouse brain

GABA-levels is summarized in Table 10.

It demonstrates that

24 or 48 hour withdrawn animals did not differ in brain GABAlevels from untreated animals.

Similarly, there was no dif-

ference in brain GABA-levels whether these withdrawn animals
showed convulsions or not.

It can also be seen in Table 9

·that 120 hour withdrawn animals did not show any convulsions and that their brain levels of GABA did not differ from
untreated animals.

J.

Ethanol Withdrawal
Symptoms
The maximum intensity of the syndrome was seen in be-

tween 5-8 hours following removal of mice from the chamber.
Table 11 shows the grading system for assessing the severity of the withdrawal reaction.

During the withdrawal,

almost all signs of the typical withdrawal syndrome
(Goldstein, 1972) were seen; these were: a) spontaneous
convulsions, or convulsions elicited either by an auditory
stimulus (buzzer used in conditioning apparatus) or by a
sharp tap on the cage or by holding the mouse up by the
tail, b) lethargy, c) tremor, and d) "tail lift."
The most useful sign to detect the withdrawal induced CNS hyperexcitability was susceptibility of mice to
audiogenic seizures; all 5-8 hour withdrawn animals showed
either mild clonic- or severe clonic-tonic convulsions upon

74

exposure to the auditory stimulus.

The syndrome then re-

gressed slowly over the next 24 hours.

4.

Effect on Brain Gamma-Aminobutyric Aci d
.Data summarized in Table lJ demons t rate the effect

of ethanol withdrawal on brain GABA-levels.

The maxim

severity of withdrawal symptoms on (Table 11) as well as
an alteration in CNS sensitivity to barbi al were (Table 12)
observed 8 hours following withdrawal, at which time brain
GAB.A-leve·ls -were significantly reduced.

Animals which

were withdrawn for 5 or 24 hours and those immediately removed from the chamber did not show as severe a withdrawal
sy:ridrome and they did not differ
spect ~

f~om

controls with re-

to levels of brain GABA.
Because pyrazole is toxic (Lelbach, 1969), we were

concerned about its contribution to the withdrawal induced
alteration in barbital narcosis (Table 12 ) and brain levels
of - GABA (Table lJ).

We, therefore, treated mice with simi-

lar : doses of pyrazole, for four days as during the actual
experiment but without exposure to ethano l , and measured
their response to barbital and their brain levels of GABA
(Table - 14).

It can be seen that pyrazole alone did not

produce any significant alteration in narc osis due to barbital ~ or :

in brain levels of GABA.
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TABLE 11
ETHANOL WITHDRAWAL SYNDROME
Degree of Abstinence
Signs

S~drome

Mild Moderate Maximum
Lethargyc

7b

Jb

ob

10/12

4

2

J

9/12

Tail lifte

4

2

0

6/12

stc;i-rtt-e to
noise

J

4

J

10/12

Audiogenic
seizuresg

0

4

8

12/12

Convulsions on
handlingh

0

6

4

10/12

Spontaneous
convulsionsi

4

0

0

4/12

Tremor

l

1

I

I

Number of
animals that showed
withdrawal reaction

d

a'l'he mice were removed from the ethanol vapour chamber 24
hours after their last dose of pyrazole. The maximum intensity of the syndrome was seen in between 5 and 8 hours.
The syndrome then regressed slowly over the next 24 hours.
The animals were observed continuously for 10 hours with
scores recorded hourly. Thereafter, observations were
made at longer intervals. Control animals did not show any
signs of withdrawal reaction.
The following controls were
run: 1. Six mice were exposed to air (without alcohol) in
an identical chamber and were given pyrazole for 4 days,
2. Ten mice were exposed to alcohol vapours for 4 days,
but were not given pyrazole.
bNumber of animals.
cMild: slow movement, Moderate: slow movement + dragging
limbs, Maximum: No movements at all.
dMild: twitching, Moderate: occasional trembling, Maximwn:
continuous tremors for 5-8 seconds.
e"Tail lift" was defined as raising the tail over the back,
one of the abnormal postures used in Freund's (1969) g r a ding of the withdrawal signs in mice. Mild: 1 tail lift/60
minutes, Moderate: 2 tail lif't/60 minut es, Maximum: J-4 tail
lift/60 minutes.
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£Startle to noise was elicited by a sharp tap on the cage
or table. Mild: Twitch lasting for about 2 seconds,
Moderate: twitch accompanied by jumping, Maximum: Twitch
followed by tonic convulsions.
gExposure of animals to a buzzer (generally used in a conditioning apparatus) produced convulsions within 3 seconds.
Moderate: mild clonic convulsions only. Maximum: severe
clonic-tonic convulsions (4 out of 8 animals died).
hConvulsions on handling was defined as h«»lding the mouse
up by · the tail.
The mouse arched his baclt, tightened his
facial _muscles into an abnormal grimace amd jerked or
twirled violently. Moderate: tightening ®f the facial
musele, . jerking and twirling, Maximum: tiWitening of the
facial _muscle, jerking, twirling and continue to convulse
when .replaced in the cage.
iMild: tonic, jumping 1 Moderate: one or tvo generalized
tonic-elonic convulsions per hour, Maximtm: three or more
generalized tonic-clonic convulsions per hour.
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TABLE 12
DURATION OF BARBITAL NARCOSIS IN MICE WITHDRAWN
FROM ETHANOL

Hours of
Withdrawal 2

1
Withdrawal Barbital Narcosis, Duration
Syndrome
Min + S.E. {N}
Intensity
Control 4
Ex2erimental3

8

3

140+8.4 (8)

56+6.la (8)

24

1

132.±9.9 (7)

95.±6.5

b

%

Change

(6)

150
28

1.

JOO mg/kg injected intraperitoneally.

2.

Number of hours after removal of mice from the ethanol
vapour-chamber, at · which time they were tested with
barbital.

J.

Prior to withdrawal, mice were given 0.5 umole/kg of
pyrazole, i.p., at o, 24, 48 and 72 hours during the
total of 96 hours of continuous exposure to an airethanol (10 mg ethanol/l i ter air) mixture.

4.

Controls were exposed concurrently to an air flow
{without ethanol) in identical chamber.

5.

Numerical grading of the withdrawal syndrome {l<J).

Control vs. Experimental
a
b

p~0.001

p < 0.02
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TABLE 13
EFFECT OF ETHANOL WITHDRAWAL ON MOUSE BRAIN LEVELS
OF GAMMA-AMINOBUTYRIC ACID

Hours
Withdrawal
of'
1 Syndrome 4
Withdrawal Intensity

umoles GABA/g Brain

J
Control

p

Experimental

2

o ~

0

2.48.±,0.0 (7)

2.56+0.09(7)

>0.05

5:

2

2.55+0.11(7)

2.46+0.12(7)

> 0.05

8 ~

3

2.55+0.11(7)

l.80+0.14(7)

< o. 005

1

2.J8+0.o8(7)

2.36.±.0.08(7)

> 0.05

24

1 • . Nll.mber : of' hours af'ter removal of' mice f'rom one ethanol
vapour-chamber, at which time they were f'rozen in
liquid nitrogen.
2.

Prior to withdrawal, the animals were given 0.5 umoles/
kg of' pyrazole, i.p., at O, 24, 48 and 72 hours during
the total of' 96 hours of' continuous exposure to an
air-ethanol (10 mg ethanol/liter air) mixture.

J.

Controls were exposed concurrently to an air-f'low
(without ethanol) in identical chamber.

4-. . Nrimerical grading of the withdrawal syndrome (1 2 J).
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TABLE 14
EFFECT OF PYRAZOLE ON BARBITAL NARCOSIS AND BRAIN LEVELS
OF GAMMA-AMINOBUTYRIC ACID IN MICE

Testi2g
Hour
Barbita1
Narcosis
(min)

4

Ethan~l

Hour

Mean + S.E. (N)
Control

Experimental

p

32

8

111+8.6 (8)

104±9.8 (8) )0.05

48

24 .

116+7.2 (8)

107+6.8 ( 8) >0.05

umoles GABA/g
brain
32

8

2.46+0.09(8)

-

. 2.43+0.10(8)>0.05

1.

Pyrazole (0.5 umole/g) injected intraperitoneally once
a day for four days.

2.

Nwnber of hours after the last injection of pyra zole,
at which t i me mice were tested with barbital or frozen
in liquid nitrogen for the determination of brain GABA.

J.

Nurnber of hours corresponding to ethanol withdrawal.

4.

JOO mg/kg injected intraperitoneally.
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DISCUSSION

't'- ; 11i no butyric acid (GABA) has been .shown to play
a role as a specific inhibitory transmitter in several
areas of the mammalian brain (Krnjevic and Schwartz, 1967;
Obata et al., 1967; Otsuka, 1972; Galindo et al., 1967) .
The non-specific depressant

ef .fe.~ts

of GABA on the mam-

malian CNS have also been demonstrated in various laboratories (Iwama and Jasper, 1957; Bhaegava and SriYastava,

1964).

Of all the depressant amino-acids present in the

mammalian central nervous system, GABA occurs in the largest amounts; moreover, it occurs m1iquely in nervous tissue
(Cooper et al.,

1970) .

Further, unlike th& monoamines, the

concentration of GABA found in the mammalian central nervous system (CNS) is in the order o~ um~les/gm rather than
nmoles/gm.

These findings suggest that , an increase in

brain levels of GABA due to a specific treatment should reduce the CNS excitability in a way that the sensitivity of
the CNS neurons to respond to a depressant drug would be
enhanced and vice versa.

Therefore, to test our hypothesis,

we selected a variety of conditions or

tre~tments

already

known to either enhance or to reduce the sensi t :!.vi ty of the
CNS to drug-induced depression and .subjected our animals to
the same treatments and measured their brain GABA-leve .l s , in
order to investigate a relationship.
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Acute exposure of mice to hypoxia has been reported
to enhance the CNS sensitivity to barbiturates (Baumel et
al., 1970b).

The potentiation of narcosis due to barbital,

which is excreted wunetabolized (Ebert et al., 1964), under
hypoxia was greater at 22°C than at J0°C ambient temperature (Baumel et al., 1970b).

The hypoxic exposure has also

been sho;vn to antagonize convulsions induced by semicarbazide or methionine sulphoximine (Baumel ~al., 1969a, b),
both drugs decrease brain GABA-levels (Killam and Bain,
1967; Roberts and Frankel, 1951).

Data obtained in the re-

search investigation showed that hypobaric exposure elevates
brain GABA at both (22 and J0°C) ambient temperatures
(Table 1).

Thus, the duration of hypoxia exposure or am-

bient temperature does not affect or interact with the effect of' low ambient oxygen on brain GABA.

However, it can

be seen in Table 1 that the increase in GABA is comparatively greater, the cause of which is not clear at present,
when mice are exposed to hypoxia at the lower ambient temperature.
Breathing of hypoxic air can lead to impairment of
brain oxidative metabolism (Gurdjian e~ al., 1949) with
possible reduc"t;ion in the use of GABA in the shunt pathway
of the Kreb's cycle.

This causes an increase in brain

levels of GABA (Wood et al., 1968), since the formation of
the aminoacid by the anarobic enzyme glutamic acid decarboxylase (GAD) is unlikely to be impaired by lack of oxygen
(Wood et al., 1968).
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Increase in levels of brain GABA have been related to
a reduction in neuronal excitability (Bennett et al., 1963).
Therefore, we suggest that hypoxia induced elevation in
brain GABA causes reduction in brain excitability, which in
turn facilitates drug induced depression.
DMI has been reported to elevate the brain sensitivity
to barbiturates at 22° but not at J0°C ambient temperature
(Shah and Lal, 1971).

TI-... is

effect of DMI on the brain se!l-

si tivi ty was related to its hypothermic ef:fect (Shal and Lal,

1971).

Thus, DMI produce3 hypothermia and potentiates nar-

cosis due to barbital at 22° but not at J0°C ambient temperature.

Our data on DMI's effect on body temperature at both

the ambient temperatures (Table 3) is in agreement with the
above finding.

It was also found that DMI, ambient tempera-

ture or their interactions had significant effect on brain
GABA-levels.

Thus, DMI caused elevation in brain GABA at

22°C but not at the higher ambient temperature (Table J).
Since J0°C ambient temperature al30 prevented DMI induced
hypothermia, it appears that hypothermia due to DMI causes
accumulation of brain GABA.

In fact, hypothermia has pre-

viously been reported to raise brain GABA-levels (O,ja et
al., 1968). Furthermore, DMI produces a dose dependent
hypothermia at 22°C (Shah and Lal, 1971), and our data
show that there was a dose-response relationship between
the dose of DMI administered and the degree of elevation in
brain GABA (Table

4, Figure 7).

Considering the aforemen-

tioned observations, we suggest that hyJ:bthermia induced
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by DMI elevates the brain levels of GABA, resulting in
lowered neuronal excitability to be reflected in enhanced
barbiturate action.
Sodium nitrite lowers the threshold of brain neurons
to drug induced depression at 22

but not at J0°C ambient

temperature (Baumel et al., 1971).

Like DMI, sodium ni-

trite produced hypothermia and potentiated narcosis due to
barbital at 22° but not at J0°C ambient temperature (Baumel
et al., 1971).

However, this effect of sodium nitrite on

the brain sensitivity was not related to its hypothermic
effect, since direct intracerebral injections of sodium nitrite failed to affect body temperature and narcosis due to
a barbiturate (Baurnel ~t al., 1970).

Instead, Baumel et al.

(1970), related the effects of sodium nitrite on brain excitability and body temperature to its hypoxic effect, because sodium nitrite induces methe·moglobinimia (Bodansky~
1951) which in turn impairs the delivery of oxygen to the
tissues (Darling and Roughton, 1942), cases hypoxia.

In

the present study, sodium nitrite elevated brain levels of
GABA and produced hypothermia at 22°C; these effects were
abolished at J0°C ambient temperature (Table

5).

Further

support that GABA may be involved facilitating sodium nitrite induced alteration in the threshold of brain neurons,
comes from the following findings of Baumel et al (1971,
1970), 1) sodium nitrite-induced poi;entiation of barbiturate narcosis was prevented by hyperbaric oxygen (OHP), and
2) sodium nitrite antagonized convulsions induced by semi-
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carbazide, both OHP (Wood et al., 1963) and semicarbazide
(Killam and Bain, 1967) reduce brain GABA-levels.

These

observations suggest that hypoxia induced by sodium nitrite
causes -accumulation of brain GABA, resulting in lowered
neuronr-.1 excitability to be reflected in enhanced barbi turate action.
Treatment of mice with pargyline at 22°C and at J0°C
ambient temperature enhances the narcosis due to barbital
(Table - 6), a drug excreted unmetabolized (Ebert et al.,
1964), and lowers body temperature (Table 6).
p~rgyline

Further,

also produces a dose-dependent hypothermia at

both the ambient temperatures (Figure 8).
tions ~ suggest

These observa-

that pargyline's ability to enhance neuronal

sensitivity to barbiturates is due to its hypothermic effect.

However, our data on pargyline's effect on brain

GABA (Table 6) show that it also raises brain GABA-levels
at both the ambient temperatures.

Moreover, there was a

dose-response relationship between the amount of pargyline
administered and the degree of elevation in GABA (Table 7,
F1g~re

9).

Pargyline has previously been shown to elevate

brain levels of GABA in mice (Schatz and Lal, 1971). Therefore, . we suggest that hypothermia induced by pargyline
causes elevation in brain GABA, resulting in lowered neuronal _excitability to be

rer~lected

in enhanced ba.rbi tura-ce

aetion • .
The ability of pargyl i ne or DMI to elevate brain
GABA may at f irst se e m paradoxical since they are used as
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antidepressants, whereas GABA has neuronal inhibi t ory properties.

It may be that GABA is not involved in mood;

pargyline's or DMI's effect on GABA is, therefo re , no t
lated to their ability to combat depression.

re-

Also, our

study involved the administration of only a single dose
of pargyline or DMI and is, therefore, short term in nature, whereas chronic administration of these drugs is
required for their ability to exhibit their antidepressant
effect.
Baumel et al. {1970) reported that chronic social
deprivation raises arousal levels of mice such that their
susceptibility to CNS depressants is reduced.

This would

predict enhanced effectiveness of CNS stimulants.

In fact,

chronically isolated mice are hypersensitive to various
stimulants {Consolo et al., 1965; Welch and Welch, 1966).
The biochemical bases of the higher arousal due to social
deprivation is not known.

Circmnstantial evidence may im-

plicate the involvement of brain serotonin.

Higher levels

of brain serotonin cause CNS depression {Jouvet, 1968),
while low brain serotonin is associated with insomnia
(Delorme et al., 1966). Social deprivation was found to reduce brain serotonin turnover (Garrattini et al.~ 1967;
Giacalone et al., 1968; Valzelli and Garrattini, 1969;
Welch and Welch, 1968).

In contrast, barbiturates and

chloral hydrate increased the concentration of serotonin
(Anderson and Bonnycastle, 1961).

'11lus, the opposing ef-

fects of social deprivation and the CNS depressants on
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brain serotonin could result in the pharmacological antagonism of these drugs.

Lal et al. (1972) reported that deple-

tion of brain serotonin after social manipulation did not
alter the sensitivity of either socially deprived or socially interacted mice to hexobarbital.

Since the arousal levels

may be related to an altered concentration of an inhibitory
transmitter and/or non-specific depressant substance, we
measured the GABA levels in the brains of mice after they
were subjected to living conditions of social deprivation
and social interaction.

Data presented in Table8 show that

brain GABA concentrations differed significantly in two
groups.

The socially interacted group showed higher brain

GABA than the socially deprived group.

Therefore, we sug-

gest that GABA plays an important role in the control of
CNS arousal as altered by social deprivation or interaction.
The reduction in GABA activity as in socially deprived
mice would be expected to reduce inhibition, or facilitate
activation, resulting in an elevated arousal-level.
The cause of lower than normal GABA levels as in
socially deprived mice could be either 1) an inhibition of
the enzyme synthesizing GABA, glutamic acid decarboxylase
(GAD); or 2) a stimulation of the enzyme degrading GABA,
GABA-alpha-keto glutaric acid transaminase (GABA-T); or

J) changes in permeability of membranes to GABA which allow the amino acid freer access to the GABA-T enzyme system.
Alternatively, a combination of two or more of these possibilities may be involved in lowering GABA following social
deprivation.
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We, theref'ore, measured the activities of' the GAD and
GABA-T in mouse brain to elucidate the mechanism of' decrease
in GABA f'ollowing social deprivation.

The activity of' GAD,

the GABA synthesizing enzyme (Baxter, 19 70), was f'ound to be
specif.ically lowered af'ter thirty days of social deprivation,
even though there was a small but signif'icant decrease in
total protein content of' the brain (Table

9).

The activity

of' GABA-T remained unaltered f'ollowing thirty days of' social
deprivation.

The third possibility that altered membrane

permeability could change brain GABA, remains to be studied.
Tlieref'ore, we suggest that reduced concentrations of' GABA
as -seen ic socially deprived mice are true ref'lections of'
brain GAD activity.
The abrupt withdrawal of' ethanol following its chronic administration reduces the sensitivity of' the CNS to
barbital induced depression (Table 12).

Barbital was se-

lected f'or the reason that it is excreted urunetabolized
(Ebert et al., 1964).
es~ablish

We measured brain GABA in order to

its relationship with ethanol abstinence-induced

alteration in CNS sensitivity to barbiturates.

To our

knowledge, the decrease in brain GABA as in ethanol withdrawn animals (Table 13) has never been reported bef'ore.
This decrease in GABA was evident only in eight hour withdr·a wn animals; they exhibited most severe abstinence syndrome (Table 13) and a greater degree of' reduction in
narcosis due to barbital (Table 12), as compared to twent yf'our hour withdrawn animals.

GABA has previously been

implicated in regulation of' neuronal excitability (B e nnett
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et al., 1963). Since GABA is an inhibitory transmitter, it
has also been implicated in the depressant actions of ethanol in the central nervous system (Hakinen and Kulonen,
1961).

Considering these properties of GABA, we suggest

that lower than normal levels of GABA as in ethanol withdrawn mice causes an increase:in neuronal excitability, which
is evident in the form of convulsions, so that the potency
of a depressant drug is altered.
The use of pyrazole in the ethanol inhalation-experiments requires justification because of its toxicity to
liver, when given alone or with ethanol (Lelbach, 1969;
Lieber et al., 1970). _F urther, not much is known about
pyrazole's action in the brain. The dose of pyrazole used
during these studies was less than 1/8 of the LD50 for mice
as reported by Goldstein and Pal (1971).

To assess the

role of pyrazole in the withdrawal induced-alteration in
brain sensitivity to barbiturates (Table 12) and GABA levels
(Table 13), we administered pyrazole alone for four days as
during the actual experiment but without ethanol and found
that it did not have any effect on brain sensitivity or
GABA levels (Table 14).

Also, pyrazole alone did not pro-

duce any of the ethanol abstinence signs listed in Table 11 •
Since brain levels of GABA in septal lesioned rats
remained Unaltered (Table 2), it seems that the alteration
in brain sensitivity to barbiturates as in the lesioned
rats might not be related to changes in brain GABA-levels.
Perhaps decrease in the acetylcholine content of the brain
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occurring after septal lesions (Sorensen and Harvey, 1971)
might be responsible for the increased sensitivity to barbiturates, since acetylcholine functions as excitatory
transmitter in various regions of the brain (Bradley, 1968).
Thus, decrease in brain content of acetylcholine could reduce the excitability of brain neurons, which in turn may
be responsible for the increased brain sensitivity to barbiturates.
Data presented in Table 10

shows that brain GABA-

levels of barbiturate withdrawn mice remained unaltered.
This indicates that GABA may not be involved in barbiturate
withdrawal induced alteration in brain sensitivity.

How-

ever, it is possible that barbiturate withdrawal might
have altered the rate of turnover of GABA.

Or perhaps

there were small but significant regional changes in brain
GABA that were not reflected in whole brain assays.
Finally, our data obtained by utilizing a variety of
conditions such as acute hypoxia, drug treatments, social
deprivation or alcohol withdrawal strongly support the
hypothesis that there is a correlation between brain sensitivity to barbiturates and brain levels of GABA.

Thus,

lowering of the threshold of brain neurons to barbiturates
caused by hypoxia, desipramine, sodium nitrite or pargyline

treat~ent

is accompanied by increase in brain levels

of GABA, a neurotransmitter at inhibitiory synapses and/or
a non-specific depressant substance.

And, increase in the

threshold of brain neurons to barbiturates due to chronic
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social deprivation or alcohol withdrawl is accompanied by
decrease in brain GABA-levels.

The utilization of differ-

ent classes of' drugs with different pharmacological properties, except for desipramine and pargyline both of which
possess antidepressant activity but have different mechanisms of action, and environmental conditions helps us to
make a generalized conclusion that brain content of GABA
plays a very important role in regulating the neuronal
sensitivity to drugs.

We have thus discovered a specific

biochemical mechanism for alteration in neuronal sensitivity to drugs.
Implications of GABA as a specific substance tha.t
regulates the neurona.l excitability ara many.

The prior

treatment with drugs known to change brain levels of GABA
may, therefore, be expected to alter the potency of central
nervous system drugs, sometimes in an undesirable mariner.
The heightened basal level o f central nervous 5ystem activity (elevated arousal) as in socially deprived mice
(Lal et al., 1972), provides suggestion as to the etiology
of certain types of schizophrenia.

Similar to certain

schizophrenic patients (Kornetzky and Mirsky, 1962), socially deprived mice are in a state of overarousal and
are less responsive to the central nervous system depressants (Lal et al ., 1972).

Since the deprivation induced

overarousal is related to deficiency of brain GABA, schizophrenic overarousal could also be :r·e lated to deficiency
GABA.

However, at best these suggestions are only specu-

lative at this time .
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SUMMARY
l.

Acute exposure to hypoxia elevates brain levels of GABA.
Low oxygen due to hypoxia causes alteration in brain
metabolism which leads to accumulation of GABA.

Since

GABA is expected to be involved in the maintenance of
appropriate levels of excitability in neurons, an increase in GABA concentrations due to hypoxia would cause
reduction in brain excitability.

Thus, lowering thresh-

old of brain neurons to drug induced depression.
2.

Rats with bilateral stereotaxically placed electrolytic
lesions of the septal area of the basal telencephalon
demonstrated marked ir..crease :Ln
sis.

ba~bi tal

ir..duced-narco-

The lesions also decreased barbital induction

time by one half.

These observations suggest that pro-

duction of septal lesions
brain neurons.

en~ances

the depression of

GABA is not involved in septal lesion-

· induced enhancement of neuronal sensitivity to drug
induced depression.

J.

Injection of desipramine raises brain GABA and lowers
body temperature.

Hypothermia due to DMT is important

in elevation of brain GABA.

Higher than normal ambient

temperature reduces brain levels of GABA .

Higher

levels of GABA due to DMI induced-hypothermia reduces
the excitability of brain neurons, so that CNS sensitivity to barbiturates is increased.
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4.

Injection of sodium nitrite elevates brain GABA and
lowers body temperature.

Hypothermia due to sodium ni-

trite is not important in raising brain levels of GABA.
We suggest that sodium nitrite induced hypoxia elevates
brain GABA which in turn reduces the neuronal excitability.

5. · Potentiation of the activity of barbital by pargyline
is due to its ability to lower the threshold of brain
neurons to drug induced depression.

Injection of

pargyline lowers body temperature and raises brain GABA.
Increase in brain GABA due to pargyline is related to
hypothermia.

Thus, increased levels of GABA reduces

the excitability of brain neuron s to such an extent that
the potency of CNS depressant drugs is altered.

6.

Mice deprived of social interactions show reduced levels
of brain GABA.

Since GABA is considered to be an in-

hibitory transmitter, reduction in GABA's activity as
in socially deprived mice would be expected to reduce
inhibition, or facilitate activation, resulting in an
elevated arousal level.

This elevation in basal level

of CNS activi ty produces alteration in the potency of
central nervous system drugs.

Reduced levels of GABA

following social deprivation are true reflections of
GAD activity.

The

ac~ivity

of GABA-T remains unaltered

following social depriva t ion. Chronic deprivation of
social stimuli also lowers the a mount of t o t al protein
in the brain.
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7.

Mice develop

physical dependence on phenobarbital whe n

their fluid intake is restricted to solutions containing increasing concentrations of the drug.

Following

withdrawal, convulsions are seen in response to the auditory stimulus.

Barbiturate withdrawal-induced alter-

ation in brain sensitivity is not related to changes in
brain GABA.

8.

Injections of pyrazole stabilizes blood alcohol-levels.
Intoxicating blood levels of ethanol for several days
in mice housed in an atmosphere of ethanol vapours produces physical dependence.

Upon removal from the al-

cohol, mice develop spontaneous or the auditory stimulus-induced convulsions.

Mice withdrawn from alcohol

demonstrated marked decrease in barbital induced
narcosis, suggesting that there is a reduction in sensitivity of brain neurons to drug induced depression.
Injections of pyrazole alone does not alter brain levels
of GABA or brain sensitivity to barbiturates.

Brain

GABA-levels decreases following alcohol withdrawal.
This indicates that reduced levels of GABA increases the
excitability of brain neurons so that their sensitiv ity
to depressant drugs is lowered.
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